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Abstract: 
The biomolecules in and around a living cell – proteins, nucleic acids, lipids, carbohydrates – continuously sam-
ple myriad conformational states that are thermally accessible at physiological temperatures.  Simultaneously, a 
given biomolecule also samples (and is sampled by) a rapidly fluctuating local environment comprised of other 
biopolymers, small molecules, water, ions, etc. that diffuse to within a few nanometers, leading to inter-molecular 
contacts that stitch together large supramolecular assemblies.  Indeed, all biological systems can be viewed as dy-
namic networks of molecular interactions.  As a complement to experimentation, molecular simulation offers a 
uniquely powerful approach to analyze biomolecular structure, mechanism, and dynamics; this is possible because 
the molecular contacts that define a complicated biomolecular system are governed by the same physical princi-
ples (forces, energetics) that characterize individual small molecules, and these simpler systems are relatively 
well-understood.  With modern algorithms and computing capabilities, simulations are now an indispensable tool 
for examining biomolecular assemblies in atomic detail, from the conformational motion in an individual protein 
to the diffusional dynamics and inter-molecular collisions in the early stages of formation of cellular-scale assem-
blies such as the ribosome.  This text introduces the physicochemical foundations of molecular simulations and 
docking, largely from the perspective of biomolecular interactions. 
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1. Introduction 
Molecular biology is highly dynamical in nature, contrary to what may be implied by the static illustrations of 
proteins, nucleic acids, and other biomolecular structures printed in textbooks.  Life occurs above absolute zero, 
and the biomolecular components in and around a cell – proteins, nucleic acids, lipids, carbohydrates – are con-
tinuously sampling, via intra-molecular interactions, the myriad conformational states that are thermally accessi-
ble at physiological temperatures.  Simultaneously, a given biomolecule also samples (and is sampled by) a rapid-
ly fluctuating local environment comprised of other biopolymers, small molecules, water, ions, etc. that diffuse to 
within a few nanometers, leading to inter-molecular interactions and the formation of supramolecular assemblies 
[1-6].  These intra- and inter-molecular contacts are governed by the same physical principles (forces, energetics) 
that characterize individual molecules and inter-atomic interactions, thereby enabling a unified picture of the 
physical basis of molecular interactions from a small set of fundamental principles [7-12].  From just a few physi-
cal laws, and several plausible assumptions, describing covalent and non-covalent (non-bonded) interactions and 
their relative magnitudes, much can be learnt about molecular interactions and dynamics as the means by which 
proteins fold into thermodynamically stable ‘native’ structures [13-15], bind other proteins or small molecules to 
trigger various cellular responses [16], act as allosteric enzymes [17-20], participate in metabolic pathways and 
regulatory circuits [21, 22], and so on — in short, all of cellular biochemistry. 
Computational approaches are well-suited to studies of molecular interactions, from the intra-molecular con-
formational sampling of individual proteins (such as membrane receptors [23] or ion channels [24]) to the diffu-
sional dynamics and inter-molecular collisions that occur in the early stages of formation of cellular-scale assem-
blies (such as a neuronal dendritic spine [25, 26]).  To study such phenomena, two major lineages of computa-
tional approaches have developed in molecular biology: physics–based methods (often referred to as simulations) 
and informatics–based approaches (often termed the data-mining or machine learning approach to knowledge 
extraction via statistical inference).  An advantage of the former approach is its physical realism [11], while an 
advantage of the latter approach is its potential to illuminate phylogenetic relationships and evolutionary features 
[27, 28].  This primer focuses on the simulation of biopolymers and molecular interactions as physical processes; 
introductory texts on bioinformatic approaches are available (e.g., Jones & Pevzner [29]). 
 
2. Motivation for computational approaches 
2.1. Molecular interactions in context: Biomolecular structure, function, & dynamics 
Life is necessarily dynamic, and it is well-established that the three-dimensional structure and dynamics of a bi-
opolymer link its sequence to its function: A specific sequence of amino acids spontaneously folds into a particu-
lar 3D shape which, together with the dynamical properties of that structure, give rise to the evolutionarily con-
served biochemical functions associated with the protein sequence [5]. However, it is becoming increasingly clear 
that biomolecular function is also defined contextually, in terms of the ligands and other biopolymers with which 
a biomolecule characteristically interacts (Fig 1A).  Consider a biopolymer such as a 150-amino acid, two-domain 
protein, denoted ‘Ƥ’ (e.g., the kinase in Fig 1C).  Imagine tracking, with high temporal (≈ ns) and spatial (≈ nm) 
resolution, a particular copy of Ƥ in a given cell (call it Ƥ1).  The physiological activities of Ƥ1 stem from its 3D 
structure and intrinsic flexibility (conformational dynamics within and between its two domains), together with (i) 
the influence of extrinsic factors such as Ƥ1’s chemical environment (redox potential, pH, ionic strength, etc.), and 
(ii) the set of molecular interactions in which Ƥ1 engages at any single instant with copies of itself and other bi-
opolymers (Q, R, …), ligands, etc.  This set of molecular contacts Ƥ1···{Q, R, …} can rapidly change, even on the 
timescale of the dozens of nanoseconds that elapse while Ƥ1 diffuses ≈ 20 Å at room temperature.  Yet even this 
simple picture has already incorporated flawed assumptions: It is now appreciated that the cytoplasm of a cell is a 
viscous medium that is densely crowded with biopolymers and other solutes with which molecular interactions 
occur (Fig 1A) [30, 3, 31, 32], making it inaccurate to model diffusion in such an environment as that in pure wa-
ter [33].  Regardless of such current limits on our understanding, this crowded and inherently dynamic environ-
ment of the cellular interior is one reason why molecular interactions and dynamics pervade biology: Biopolymers 
fold into native 3D conformations; monomers self-assemble into higher-order structural units that often are the 
functional entities (e.g., an oligomeric enzyme with a composite active site at a subunit interface [34, 35]); ions 
traverse the pores of membrane channels [24, 36, 37]; motor proteins and other factors diffuse along one-
dimensional tracks (DNA, cytoskeletal filaments, etc. [38, 39]), and so on.  All of these dynamical processes in-
volve the formation and dissociation of molecular contacts that vary greatly in type, number, and duration. 
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2.2. Simulation as a complement to experimentation 
Experimentation, computation, and theory are highly complementary.  Experimental data are real, but unambigu-
ous results demand a flawless set of control experiments, and even then the results are generally not readily (di-
rectly) interpretable at an atomic or molecular level; understanding and knowledge emerge gradually, via efforts 
to interpret experimental data in terms of an underlying theoretical model (e.g., fitting ligand-binding data to 
chemical equilibria equations and isotherms [40]).  With molecular simulations and other forms of computation, 
virtually any imaginable approach can be devised, implemented, and then applied in order to gain insight for near-
ly any biomolecular system, at potentially ultra-high resolution in terms of length– (atomic) and time– (sub-ps) 
scales.  However, the degree of correctness and realism is not always clear due to the assumptions, limited sam-
pling, etc. that make the calculations feasible in the first place (precision is more readily assessed than accuracy, 
especially with computational results) [41-44].  There is no substitute for experimental data, and computational 
results may be best viewed as more predictive and interpretative than conclusive; together, computation and ex-
perimentation can aid the testing and development of coherent theories for the mechanism of a biomolecular phe-
nomenon. 
Simulation approaches are especially well-suited to studies of biomolecular structure and dynamics, for rea-
sons that range from conceptual to practical.  Conceptually, many computational methods have developed out of 
the same physical theories (usually statistical mechanics) used to describe biopolymer structure and thermody-
namics [45, 11], making computational approaches the natural bridge between experimental data and the models 
(theories) used to interpret such data [46-48].  In practical terms, two distinct types of issues arise.  The first issue 
is true for all bio-systems: Some experimental methods are inherently limited for certain types of questions for 
any biomolecular system.  The second issue is true of all experimental methods: Some biomolecular systems are 
experimentally less tractable than others, with the nature of the experimental limitation depending on the precise 
question.  As an example, consider the problem of extracting information about the dynamics of a protein•ligand 
complex at both atomic resolution and over the potentially relevant ns ↔ ms timescales (Fig 2).  Crystallography 
is not readily applied to this problem because a protein•ligand crystal structure is a spatially and temporally aver-
aged model, the averages being taken over more than 1012 unit cells (a conservative estimate, for μm-sized crys-
tals of typical cell dimensions) and timespans greater than hundreds of milliseconds (a conservative estimate, for 
exposure with high-brilliance synchrotron X-rays).  The development of time-resolved diffraction approaches [49, 
50] is an active area of research that can benefit from simulation approaches [51] as well as new experimental ca-
pabilities [52]. Solution-state NMR relaxation measurements offer another experimental methodology to study 
dynamics, but this approach can be hampered by fundamental timescale issues and by the need to fit data to a pri-
ori assumptions about motional modes (see, e.g., [53, 54] for discussions). 
A basic problem for the diffraction and spectroscopic approaches is that, as structural biology has advanced, 
many of the systems of contemporary interest are large, dynamic assemblies that may be only transiently stable 
(e.g., membrane protein complexes [55], the RNA-processing spliceosome [56]).  High-resolution crystallograph-
ic or NMR studies of such systems are hindered by precisely those features that may be of greatest biological in-
terest — conformational heterogeneity in the population on the timescale of the experiment, dynamical inter-
conversions between stable sub-states (some sub-states may be more ‘druggable’ [57, 58]), and so on.  Diffraction 
studies require well-ordered crystals, and crystallization requires a supersaturated population of molecules or 
complexes [59]; excessive structural variability among the entities will impede their packing into a geometrically 
ordered lattice (or, even if they do, the lattice may diffract only poorly due to severe mosaicity or other defects 
[60]).  Similarly, in NMR structure determination [61] the dynamical regions are generally the least well-resolved, 
and approaches to extract dynamics are beset by potential limitations; for instance, the model-free approach to 
infer dynamics from spin relaxation measurements assumes decoupling of global (e.g., protein tumbling) and in-
ternal (e.g., domain hinge-bending) modes, which is problematic for large-scale, high-amplitude fluctuations such 
as between two protein domains [54].  Also, electron paramagnetic resonance (EPR) spectral line-shapes can be 
analyzed to infer ns–scale protein backbone dynamics [62], but this approach alone is not without caveats.  Com-
putational approaches such as MD simulation offer an appealing route to exploring molecular flexibility and in-
teractions in full atomic detail, particularly when the desired information is experimentally inaccessible because 
of these methodological limitations. 
2.3. Scope of this text 
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Biomolecular simulation is a vast subject.  The remainder of this primer focuses on MD simulations and in silico 
docking, as these are two common computational approaches in the modern biosciences.  Also, MD simulations 
have taken on renewed significance as ultra-long (μs–ms-scale) atomistic simulations are becoming tractable be-
cause of advances in hardware, software, and algorithms [63-67, 48, 68, 69].  Intriguing conformational transi-
tions on biologically relevant timescales (μs and beyond; Fig 2) are becoming increasingly accessible using clas-
sical MD simulations because of these developments, in addition to a host of ‘enhanced sampling’ methods that 
have been under continual development [70, 71, 18, 72].  In what follows, basic concepts (§3) are emphasized 
rather than practical recipes, with the focus being on MD simulations (§4) and docking (§5).  The fundamental 
principles — conformational sampling, dynamics integrators, force-fields, etc. — appear at the core of most mod-
ern computational approaches, including MD and docking.  In addition, many interrelated families of techniques 
derive from the basic MD and docking methodologies, such as coarse-graining [73, 74], simulated annealing 
structure refinement [75], structure prediction [14, 76, 15], flexible ligand docking [77], protein–protein docking 
[78-80], and so on. 
 
3. Physical principles, Computational concepts 
The conceptual foundation and practical basis of MD simulations and related approaches, such as Monte Carlo 
sampling [81, 82], can be appreciated by considering a few key principles.  The idea of energy surfaces is a unify-
ing physical principle, and conformational sampling of the energy landscape is often the computational goal, in 
both MD and docking.  These and related statistical mechanical concepts are described in this section. 
3.1. Statistical mechanics in a nutshell 
3.1.1. Why is it necessary? 
Statistical mechanics is the theoretical framework linking the microscopic (atomic-level) properties of a molecule 
to its thermodynamic properties on bulk/macroscopic scales of, e.g., 1023 molecules in a vial.  To see the need for 
such a theory, consider an idealized system comprised of a single molecule in complete isolation at T = 0 K.  Its 
bond angles, zero-point energy, dipole moment, and other microscopic properties could be computed with reason-
able accuracy via quantum mechanics, were the molecule small enough (tens to hundreds of atoms) for the calcu-
lations to be feasible at the desired level of QM theory [83].  A molecule under such isolated conditions possesses 
only a (QM-computable) potential energy, also known as its internal energy, 𝒰; much of this energy may exist, 
for instance, by virtue of ring-strain or steric constraints that prevent the molecule from adopting an even lower-
energy conformation.  Such a system is computationally tractable, but of limited biochemical relevance.  Of 
greater relevance might be the same molecule at finite temperatures (e.g., T = 310 K for humans) and on much 
larger scales, say with 1023 copies of the compound floating about in vitro during a biochemical assay.  It is far 
less straightforward to imagine computing the physical properties (energies, compressibility, etc.) of this bulk sys-
tem: In addition to the sheer number (𝑁 ≈ 𝑁A) of particles, there is a combinatorial explosion in the number of 
possible system configurations that must be considered (already ~2𝑁A if there are only two possible states per par-
ticle!); there is now kinetic energy to also take into account, which is the thermal energy of a particle by virtue of 
it being above absolute zero (often denoted as 𝒦); there is a continuously dynamical exchange between potential 
and kinetic energies, the sum of which is the system Hamiltonian (ℋ = 𝒰 + 𝒦 for a closed system); there is now a 
virtual infinitude of potential configurations of system components relative to one another (≈ 𝑁A2 pairwise interac-
tions, to say nothing of three-body and higher-order interactions); there is coupling between the dynamical inter-
actions between particles (inter-molecular dynamics) and the conformational degrees of freedom within individual 
flexible particles (intra-molecular dynamics); and so on. 
3.1.2. Why, and how, does it work? 
Despite the complex picture described above, the situation is not hopeless if we take a statistical rather than de-
terministic approach, using probabilistic formulations such as the Boltzmann distribution (Box 2 and below) to 
describe populations of particles in terms of distributions of microstates and properties (position, velocity, etc.).  
We compute averages of properties from the statistical distributions, limiting ourselves to bulk scales beyond 
𝑁 > 103 particles; population sizes less than this are too small.  The central pillar of statistical mechanics is a 
purely numerical property of random variables: (i) larger populations have smaller variances in their means (the 
law of large numbers), and (ii) large populations of independent random variables tend towards the normal distri-
bution (the central limit theorem [84]), with the standard deviation of the mean for a sample (𝜎𝑠) drawn from a 
population of size 𝑁 scaling as 𝜎𝑝 √𝑁⁄ , where 𝜎𝑝 is the population standard deviation.  As population sizes ap-
Mura & McAnany (2014), An Introduction to Biomolecular Simulations and Docking 4 
 
proach the 𝑁A molecules in a test-tube (e.g., in a calorimetry experiment), the probability density functions (p.d.f.) 
for any observable/bulk quantity become so strongly spiked that the mean statistical values can be taken as single, 
well-defined thermodynamic quantities (entropy, free energy, etc.), rather than distributions of values [85, 86].  
This asymptotic behavior, 𝜎𝑠 ~ 0 as 𝑁 → ∞, is known as the thermodynamic limit.  Thus, while individual parti-
cles in a system of, say, 105 particles may have drastically different individual energies, the mean energy of the 
system will be essentially a single, well-defined value known as the internal energy, 〈𝐸〉 = 𝒰; the same is true for 
all bulk properties, such as the heat capacity, entropy, etc. 
To illustrate a bulk thermodynamic property in terms of the underlying statistical distributions, consider the 
entropy (𝑆) of a system of 𝑁 hard spheres.  The entropy is a function of the 6𝑁 particle positions and momenta for 
the system in discrete microstates 𝑖 = 1, 2, 3, …, and is expressible as a sum over these microstates: 
𝑆 = −𝑘B∑ 𝑝𝑖𝑖 ln𝑝𝑖       (1) 
In the above, known as the Gibbs entropy formula, 𝑘B is the Boltzmann constant and 𝑝𝑖 is the probability of occu-
pation of microstate 𝑖.  An instructive exercise is to consider the Eq 1 summation for the extreme cases of (i) a 
perfectly uniform distribution (𝑝1 = 𝑝2 = ⋯ = 𝑝𝑁 = 1𝑁) and (ii) a singly-spiked distribution (𝑝𝑖 = 1 for one 𝑖); note 
that, because an infinitude of microstates exist as a continuum in classical dynamics (Fig 3), discrete sums are 
replaced by integrals in classical statistical mechanics.  While the entropy is a measure of the p.d.f. of microstates 
and is a property of the ensemble (Box 2) of particles, it is also a statistical quantity itself – that is, there exists a 
distribution of entropy values for a system of 𝑁 particles, too, and that sampling distribution has means (〈𝑆〉), var-
iances (𝜎2(𝑆)), and so on.  Consider how this distribution of entropy values varies with system size, 𝑁.  The en-
tropy for simple model systems can be computed and plotted for ensembles of size 𝑁 = 1, 2, … ,𝑁A particles.  Ex-
trapolating to 𝑁 ≈ 𝑁𝐴 particles, the probability distribution of the entropy p.d.f. becomes infinitely narrow.  To 
see this, consider the exponential growth of the central (𝑘 ≈ 𝑛 2⁄ ) binomial coefficients �𝑛𝑘� = 𝑛! 𝑘! (𝑛 − 𝑘)!⁄  for 
𝑛 = 1, 2, … ,𝑁A coin flip trials, and consider the essentially zero deviation from a 1:1 heads:tails ratio for this se-
ries of flips when 𝑛 ≈ 𝑁A.  In the same way, the distributions of entropy values become so sharply spiked that 
there are only infinitesimal deviations from the means, 〈𝑆〉, with 𝛿𝑆 ≈ 0 as 𝑁 → 𝑁𝐴. These statistical quantities are 
precisely the usual thermodynamic properties with which one is familiar, and which can be determined via exper-
imental measurements.  Boltzmann showed that for the microcanonical ensemble (Box 2), which corresponds to a 
constant number of particles (𝑁), volume (𝑉), and energy (𝐸), the system entropy is 𝑆 = 𝑘B ln(Ω(𝑁,𝑉,𝐸)), where 
Ω is the number of accessible microstates (Fig 3A) and is a function of only 𝑁,𝑉,𝐸.  In this way — as statistical 
quantities and asymptotic distributions — all the usual thermodynamic potentials take on statistically well-defined 
(i.e. meaningful) average values on bulk scales. 
A biomolecular example to illustrate this general approach would be to consider 105 random conformations of 
a protein of interest.  We can calculate the energy of each of those conformations using the methods of molecular 
mechanics [8].  Then, given these energies and the Boltzmann distribution, we can evaluate the distribution of 
conformational states of the protein and also determine the bulk thermodynamic properties of the ensemble [45].  
In Maxwell-Boltzmann statistics, the probability of occurrence of state i with associated energy ε𝑖 (〈ε〉 = 𝒰) is: 
𝑝𝑖 = 𝑒−ε𝑖 𝑘B𝑇⁄𝑍          (2) 
where 𝑘B is the Boltzmann constant, 𝑇 is the absolute temperature, and 𝑍 is a normalization constant to ensure 
that the probabilities sum to unity.  This normalization factor is known as the partition function [86], and it equals 
the sum over all microstates 𝑖.  That is, 𝑍 = ∑ 𝑒−ε𝑖 𝑘B𝑇⁄𝑖  in a quantum mechanical formulation; in the classical lim-
it of infinitesimally spaced energy levels, integrals replace discrete sums.  Also, this brief introduction does not 
distinguish between the foregoing molecular partition function and the canonical partition function for an ensem-
ble of 𝑁 particles at fixed volume and temperature (the 𝑁𝑉𝑇 ensemble [Box 2]); for the canonical ensemble, the 
total energy of the system in state 𝑖, 𝐸𝑖, appears in the argument of the exponential.  Though the partition function 
arises as the simple requirement of a valid probability distribution, it is the central link between microscopic 
properties and macroscopic observables.  Indeed, the partition function is a thermodynamic quantity, as seen in 
the close relationship between the Helmholtz free energy (𝐴) and the canonical partition function: 
     𝐴 = −𝑘B𝑇 ln𝑍        (3) 
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The practical utility of this is the following: Potential energies often can be readily calculated for a given system 
and, because 𝑍 depends on the distribution of potential energies, the results from a computer simulation can pro-
vide a description of the partition function.  Then, using relations such as Eq 3, the free energy of a system can be 
calculated directly; recall that free energy 𝐴 (= 𝒰 − 𝑇𝑆) gives the maximum amount of work that a closed ther-
modynamic system can do (in the canonical ensemble, 𝐴 is minimized at equilibrium).  Finally, using the standard 
Maxwell relations [87], such as the fact that (𝜕𝑇 𝜕𝑉⁄ )𝑆 = −(𝜕𝑃 𝜕𝑆⁄ )𝑉, every thermodynamic quantity (pressure, 
heat capacity, virial coefficients, etc.) can be derived from this point [88].  Further information on statistical me-
chanics can be found in Widom’s cogent introduction [86] and McQuarrie’s [85] comprehensive treatment. 
3.1.3. What must we consider? 
The aforementioned statistical quantities are functions of the probability densities of microstates and their associ-
ated energetics.  Molecular energetics, in turn, vary with molecular structure (loosely, potential energy) and dy-
namics (loosely, kinetic energy).  The many aspects of molecular structure and dynamics can be synthesized into 
a coherent framework by considering four basic principles: (i) interactions are shaped by the structural and physi-
cochemical properties of inter-atomic contacts; (ii) interactions are dynamical, and the macroscopic properties of 
a system at equilibrium (e.g., ligand-binding free energies [89, 90]) could be exactly computed given full 
knowledge about the microscopic dynamics of the system’s phase space (all possible microscopic states, popula-
tions of the microstates, transitions between them, etc.; Fig 3); (iii) the relative population of different regions of 
phase space (Fig 3B) define energy surfaces for the system of molecular interactions (free energy surface, poten-
tial energy surface); and (iv) these energy surfaces are sampled (basins are populated, barriers are crossed) as the 
biomolecular system dynamically evolves along a trajectory in phase space.  These four considerations — physi-
cochemical interactions, dynamics in phase space, energy surfaces, and conformational sampling — provide a 
foundation for understanding biomolecular simulations, as described in the remainder of this section. 
3.2. Physicochemical nature of molecular interactions 
Structure and dynamics govern the molecular recognition processes that define the function of a biomolecule.  
These recognition events involve the non-covalent interactions that occur between the standard chemical func-
tionalities in biopolymers and organic compounds – amines, hydroxyls, carboxylates, amides, aromatic rings, thi-
ols, etc.  Viewed hierarchically, a molecular machine as complex as the ribosome (Fig 1B) is simply a specific 
geometric arrangement of inter-atomic contacts between such functional groups (structure), and its stability is 
modulated by the dynamics of these intra- and inter-molecular contacts.  Accurate molecular simulations of intra- 
and inter-molecular contacts require accurate treatment of two basic types of non-bonded interactions: electrostat-
ic interactions [91] and van der Waals (vdW) forces [92]. 
Electrostatic and vdW interactions differ in their relative magnitudes and in how that magnitude varies with 
distance between the interacting atoms (𝑟1,2). While electrostatic interactions can often be an order of magnitude 
stronger than vdW energies, both forms of interaction vary greatly with intrinsic factors, such as the types of at-
oms and bonding involved (element type, hybridization, etc.), as well as extrinsic factors such as the dielectric of 
the local environment (‘ϵ’ in the denominator of the Coulombic term in Eq 5 below, which attenuates electrostatic 
forces).  Electrostatic interactions occur between chemical groups that bear formal positive or negative charges 
(ion pairs, ‘salt bridges’), or that contain highly electronegative atomic centers with substantial partial charges 
(the D–Hδ+∙∙∙∙–δA of a hydrogen bond donor/acceptor pair). As a general term for all other (non-electrostatic) forc-
es, van der Waals interactions include forces between two permanent dipoles, a dipole and an induced dipole, or 
two induced dipoles (the latter are also known as London dispersion forces [92]).  Electrostatic forces decay slow-
ly with the distance between interacting centers (Coulombic forces 𝐹 ∼ 1 𝑟2⁄ , energies 𝑈el ∼ 1 𝑟⁄ ) and are therefore 
referred to as long-range, while vdW forces are considerably more short-ranged.  VdW interactions are generally 
modeled by a Lennard-Jones potential (Eq 5), which contains a 1 𝑟6⁄  attractive component that is rooted in the 
quantum mechanics of London dispersion forces and a 1 𝑟12⁄  term to capture hard-sphere/exchange repulsion (not 
physically-based, a numerically convenient expression that can be computed as the square of the 𝑟−6 term [88]). 
Though additional types of interatomic ‘forces’ are occasionally invoked, such as hydrogen bonding, these are 
not distinct physicochemical forces.  For example, H-bonds, though directional like covalent bonds, are funda-
mentally electrostatic in nature.  Similarly, the hydrophobic effect, which is an important consideration in ligand-
binding and drug design, is not a distinct physical force but rather a physical effect that stems from the above 
forces (electrostatics, vdW) as applied to the properties of liquid H2O (dipole moment, H-bonding, clathrate-like 
structures of H-bond networks [93]) under the laws of thermodynamics; the effect is interfacial and is entropically 
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driven (see, e.g., Ch. 8 in [92] and refs. [94-96]).  Because electrostatics and vdW interactions are the only fun-
damental types of intermolecular forces of relevance to biopolymers, molecular mechanics (MM)–based force-
field equations are simple in overall functional form (§4.3 and Eq 5, below).  These functions, or potentials (a 
term synonymous with force-field), consist of a limited number of bonded and non-bonded terms, usually with all 
interactions taken as pairwise.  The bonded terms represent displacements of bond lengths (stretching), angles 
(bending), and rotations about covalent bonds (torsional angle); these deviations are modeled as harmonic springs 
(bonds, angles) or periodic rotation (torsional barrier). The nonbonded terms, which capture all the electrostatic 
and vdW interactions, correspond to contacts that may be intra-molecular, if the two atoms are in the same mole-
cule (such as between the two domains of the kinase in Fig 1C), or inter-molecular, if the contact occurs between 
entities in different molecules (such as the antibiotic and the ribosome in Fig 1B).  Inclusion of electronic polar-
izability in FFs is an active area of research, as mentioned below and in Box 4. 
In summary, electrostatics and vdW forces are what dictate the structure and energetics of biopolymer fold-
ing, assembly, and dynamics, as well as the binding of small molecules, such as antibiotics or other drug com-
pounds, to molecular complexes.  Note that even those physiological processes which may not seem non-covalent 
in character ― e.g., electronic transitions accompanying bond formation/rupture, photochemical processes ― are 
still modulated by non-bonded interactions in vivo.  For instance, the signal transduction cascades underlying vi-
sion rely on the covalent attachment of a small polyene known as retinal to the protein opsin, giving a photo-
activatable membrane receptor known as rhodopsin [97, 98].  For this to ever occur, the retinal molecule must 
diffuse to its binding-site in opsin, where it undergoes photon-triggered cis → trans isomerization in the sterically 
crowded protein interior; thus, intricate dynamics are at play in each stage of this process.  In this sense, molecu-
lar dynamics govern virtually all physiological processes, even electronic or photochemical ones. 
3.3. Dynamical processes and phase space 
The formation and stability of molecular interactions are modulated by dynamical processes spanning several 
decades, ranging from ps-scale rotations of solvent-exposed side-chains near a ligand-binding site to much longer 
time (≈ ms–μs) collective motions that enable allosteric communication (Fig 2; see [99, 100, 58, 101] for exam-
ples).  For macromolecules, there are three aspects of any dynamical process to consider: (i) the timescale of the 
elementary process; (ii) the spatial extent over which the event occurs; and (iii) the amplitude of motion.  The no-
tion of characteristic times is perhaps the most intuitive of these features: as suggested in Fig 2, various types of 
dynamical processes occur on timespans that may be narrow and well-defined (e.g., bond vibration), or possibly 
much broader windows (the collective motions involved in allostery, gated ligand-binding, and biopolymer fold-
ing can span several log units [7]).  The spatial extent may be small and highly localized (bond vibration, side-
chain rotation), or the dynamical process may occur on the length-scale of an entire protein domain, such as in a 
hinge motion.  A similar but not identical concept is the amplitude of oscillatory motion: fluctuations may occur 
on small or large spatial extents (e.g. two domains of a protein). And, independent of this length-scale, the ampli-
tude itself may correspond to small-scale (≈ Å), high-frequency motion (≈ ns times, corresponding to ≈ GHz in 
the frequency domain) or larger amplitude (>10 Å), low-frequency (≈ μs-scale) motion.  As implied in the forego-
ing, the frequency and amplitude of motion are often inversely related; this is because a motional mode can be 
estimated as a normal mode oscillation under a quadratic potential (i.e., harmonic oscillation), for which the 
mean-square fluctuation for a given amount of energy is 𝑘B𝑇 𝜔𝑖2⁄ , where 𝜔𝑖 is the frequency of mode 𝑖 [102].  
Slow, high-amplitude motions correspond to ‘soft’ modes that often involve rearrangements of large structural 
units (helices, sheets, entire domains) and occur over large spatial extents (domains, not side-chains).  These long-
time dynamics consist of rigid-body motions such as the shearing or twisting of secondary structural elements, the 
rocking of one domain with respect to another about a hinge, and so on.  Low-frequency, high-amplitude motions 
can be thought of as being ‘slower’ because they entail extensive sampling of conformational space, wherein the 
motions of neighboring regions are correlated partly by chance (thermal motions are random), partly by virtue of 
the pattern of hydrogen-bond connectivity in, say, an α-helix versus a β-strand, and partly by the spatial pattern of 
other nonbonded interactions between secondary structural elements.  These correlated types of motions play key 
roles in cooperativity and allosteric communication between distant sites in a protein, and also in the fluctuations 
that modulate the binding of ligands to an effector site [103].  Because long-time dynamics are relatively slow, 
their time regimes can also overlap the diffusional association of two molecules, which is the first step in molecu-
lar recognition.  
The preceding discussion implicitly focused on the dynamics of a single biopolymer in isolation.  How do the 
dynamics of a single protein relate to the behavior of a bulk quantity (𝑁A molecules), as measured in a biochemi-
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cal assay of, say, ligand–binding affinities?  By linking microscopic, atomic-scale dynamics to the macroscop-
ic/thermodynamic properties of a system of molecules, the three concepts of phase space, ensembles, and er-
godicity answer this question and provide a complete framework to elucidate how experimental (bulk) quantities 
relate to the physical and dynamical properties of the system’s constituents.  Box 2 and the legend to Fig 3 sum-
marize these statistical mechanical concepts.  The principle of ergodicity is that an ensemble (bulk) average of 
some property of a dynamical system asymptotically converges to the time-average of that property, as described 
below (§3.5).  This is the fundamental theoretical justification that allows one to perform MD simulations of sin-
gle molecules or complexes, versus the computationally unfeasible task of trying to simulate all ≈ 𝑁A molecules 
in a test tube. 
3.4. A unifying physical picture: Degrees of freedom, energy surfaces 
Molecular interactions, A∙∙∙B, between biopolymers and ligands involve an extraordinary number of degrees of 
freedom (DoF).  A DoF is simply a well-defined parameter that quantifies some property (typically geometric) of 
a system, where the parameter is free to vary across a range of values independently of other degrees of freedom.  
Together, all the DoFs define the precise state of a system.  For example, a one-dimensional spring at rest is char-
acterized by a specific mechanical equilibrium length, 𝑥eq; as the spring executes dynamics in accord with 
Hooke’s law, the length at time 𝑡, 𝑥(𝑡), deviates either as a compression or extension.  This deviation (𝑥 − 𝑥𝑒𝑞) is 
a translational DoF of the spring.  Analogously, rotation about the central bond in ethane (𝜑) is an angular DoF, 
with well-defined bounds of 𝜑 ∈ [0, 2𝜋].  For both the macroscopic spring and microscopic ethane molecule, the 
energy 𝐸 (and its negative gradient, the force ?⃗? = −∇𝐸) is typically some particular function of the DoF: The 
spring’s energy varies quadratically with its sole DoF (Fig 2), defining a parabolic energy surface, while the 
ethane molecule’s potential energy varies periodically with the dihedral 𝜑 (see the sinusoidal torsion angle term in 
the FF equation of §4.3).  For a system with 𝑛 DoF, the energy surface is simply an 𝑛-dimensional surface, in 
𝑛+1–dimensional space, giving the energy as a function of the 𝑛 degrees of freedom [104, 8]. 
The energy surface concept is entirely generic: Surfaces may correspond to only potential energy terms, as in 
molecular mechanics, or they may also include thermal energy, thereby corresponding to free energies (as in mo-
lecular dynamics).  The hyper-dimensional energy surface may be fairly smooth ― imagine a simple molecule 
such as butane in vacuo (few DoF).  Or, the surface may be corrugated [105, 106], with peaks and valleys of vast-
ly differing magnitude and shape ― imagine a protein surrounded by solvent (solvent DoF also would need to be 
accounted for in computing the energetics of the system).  A molecule of 𝑁 atoms in three-dimensional space has 3𝑁 degrees of freedom, of which 3𝑁–6 are vibrational (3𝑁–5 if the molecule is linear), and the system’s confor-
mational energy surface can be naturally expressed in terms of these 3𝑁–6 DoF as a vibrational basis set. 
Because of its generality, the energy surface offers an integrated physical picture for all aspects of molecular 
structure, dynamics, thermodynamics, and kinetics.  How is this possible?  Consider a protein Ƥ and two of its 
possible states, ƤA and ƤB (e.g., active and inactive states of the protein kinase in Fig 1C).  ƤA is a specific 3D 
structure (conformation) that maps to a particular point on the energy surface, and transitions between structural 
conformers (ƤA→ƤB, ƤA←ƤB) occur via dynamical paths (trajectories) along this energy surface. Such transitions 
persistently occur at finite temperature, assuming any energy barriers between A and B to be surmountable; and, 
at thermodynamic equilibrium there will be no net change in the relative populations of different regions of the 
energy surface (valleys, peaks, plateaus).  These relative populations reflect macroscopic/thermodynamic energy 
differences (recall the Boltzmann distribution), while the microscopic details of the transition paths – barrier 
shapes and heights – dictate the kinetic properties for elementary, single-step transitions in this ‘two-state’ behav-
ior.  The discrete states A and B, corresponding to two basins in the energy surface, can be discrete structural or 
functional states of protein Ƥ or any dynamical process (A/B may be bound/unbound, folded/unfolded, etc.).  
Peaks (local maxima) along a pathway from ƤA ↔ ƤB are transition states, while states A and B themselves are 
preferentially populated and are referred to as local minima.  The depth of a particular basin in a ‘funneled’ land-
scape is its enthalpy, while the width of the energy surface near this local minimum reflects the entropy of that 
state. (Recall that entropy is a measure of the number of thermally accessible states, so a wide/shallow basin cor-
responds to greater entropy than does a narrow/deep one; this ‘entropy/enthalpy compensation’ is why the deep-
est basin is not necessarily the unique global free energy minimum [47].)  If the energy surface under considera-
tion is the Gibbs free energy, the relative populations of ƤA and ƤB can be used to compute standard-state free 
energy differences (Δ𝐺°) for folding, ligand-binding [89, 107], or any other A ⇌ B process of interest.  Again, 
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statistical mechanics is the link between the microscopic dynamics of a single particle on the energy surface and 
the bulk behavior of an ensemble of particles. 
If biomolecular energy surfaces could be fully mapped, we could compute any property of interest for a par-
ticular system and its dynamics.  However, the sheer number of DoFs for even simple biopolymers leads to an 
exponentially vast conformational space, making exhaustive exploration of macromolecular energy surfaces an 
impossible task.  The high dimensionality of energy surfaces poses many difficulties, so conformational sampling 
of the surfaces becomes the crucial computational challenge. 
3.5. A key computational goal: Conformational sampling 
Because we are often concerned with the bulk properties of a system, as determined via experiments, our essential 
computational goal is to sample molecular conformations across the energy landscape, in accord with a well-
defined statistical mechanical ensemble.  Thermodynamic equilibrium is generally assumed in such sampling, 
though this is not strictly necessary; for instance, there exist ‘steered’ and ‘biased’ simulation methods that are the 
computational analog of non-equilibrium, single-molecule ‘pulling’ experiments [108].  If conformational sam-
pling is done properly – with properly-weighted microstates and sufficient sampling – then we can compute accu-
rate means, deviations, and other statistical values for many types of potentially interesting properties, including 
(a) structural features, such as the radius of gyration; (b) thermodynamic quantities, such as entropies and free 
energies; and (c) dynamical properties that supply kinetic/mechanistic insights, such as the correlation time for 
the motion of a specific loop that ‘gates’ the binding of ligands to an effector site on a protein [109]. 
3.5.1. Three types of methods, based on structure, thermodynamics, & kinetics 
Conformational sampling approaches can be distinguished from one another based on whether they supply in-
formation about problem types (a), (b), or (c), listed above.  For instance, some sampling methods focus solely on 
generating conformations and evaluating their energies, perhaps as trial conformers for structure prediction or for 
NMR structure determination.  In such approaches, which address problem domain (a), the ‘energies’ can be 
viewed very generally ― not necessarily as physical quantities, but rather as the values of objective functions that 
quantify the discrepancy between a candidate structure and the experimental data.  With sufficiently extensive 
sampling, optimal agreement between a structural ensemble and experimental data can be achieved by minimiz-
ing/maximizing such target functions [75].  The sampling techniques in this class of methodologies – e.g., dis-
tance geometry methods, genetic algorithms – are largely heuristic and often are not physically-based, though 
they can be highly effective ways to sample conformational space from a purely structural perspective (problem 
type (a)).  To illustrate the flexibility of these ideas, note that non-physical sampling methods, such as genetic 
algorithms [8], can be combined with physics-based descriptions of molecular interactions, such as an MM-based 
force-field, as done in the AUTODOCK software for protein/ligand docking [110]. 
Turning to the two other classes of approaches, (b) and (c), an advantage of physics-based sampling tech-
niques is that they can be used to compute thermodynamic quantities (problem type (b)).  The two families of 
such methods are distinguished by whether or not the method aims to simulate the underlying dynamics of the 
system.  The first family of approaches, exemplified by Monte Carlo sampling [82], provides correct, Boltzmann-
weighted sampling of an ensemble, but does not attempt to simulate the actual microscopic dynamics of the en-
semble.  Such methods can be used to address questions of structure (a, above) and thermodynamics (b, above), 
but not kinetics (c, above) [111, 8, 81, 10].  The second family of physics-inspired methods seeks to model – with 
physical realism – the underlying dynamical processes.  These simulation-based approaches, of which MD simu-
lations are a prime example, can supply detailed information on structural (a), thermodynamic (b), and kinetic (c) 
properties.  Simulation methodologies range from a high level of detail, such as all-atom MD incorporating ex-
plicit solvent molecules [46], to ‘implicit solvent’ models [112] that enable more extensive sampling (longer sim-
ulations) by treating the solvent as a dielectric continuum (thus reducing the number of DoFs), to further simpli-
fied ‘coarse-grain’ models (e.g., each amino acid modeled as a bead that interacts with other residues under an 
effective pair potential that has been calibrated for such simulations [73, 113, 114]).  MD-based simulation meth-
ods can be applied to study the conformational dynamics of single proteins, and even molecular assemblies as 
complex as the ribosome [115, 116] or as large as an entire HIV capsid [117].  To simulate molecular contacts 
and diffusional association on long timescales and large spatial domains, Brownian dynamics (BD) methods can 
be applied [118, 119].  The BD approach typically treats the interacting molecules as rigid; thus, although diffu-
sion-controlled reactions and the long-time behavior of large systems can be simulated, atomically-detailed dy-
namics are not modelled (see below).  To clarify the relationships between various sampling methods, two preva-
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lent approaches (MD and MC) are compared in Fig 3; further information on conformational sampling and related 
simulation issues can be found in van Gunsteren et al. [47]. 
3.5.2. Langevin dynamics as a general framework 
The MD and BD simulation approaches can both be understood as limiting cases of a single formulation of 
classical dynamics, namely Langevin dynamics (LD).  As described below (§4), the central equation in MD is 
Newton’s second law, ?⃗? = 𝑚?⃗?, which describes the classical mechanics of macroscopic systems.  The Langevin 
equation [120, 121, 10] is a phenomenological extension of this law which renders it more generally suitable for 
dynamic simulations, such as in implicit solvent (e.g., no explicit H2O molecules, but need to model a stochastic 
heat bath).  In LD, two terms are added to Newton’s equation: (i) a frictional term that captures dissipative effects, 
such as frictional drag of solvent molecules on the solute, and (ii) a noise term that corresponds to Gaussian-
distributed white noise, in order to model the random collisions and ‘kicks’ between solvent and solute molecules.  
These terms, which make the Langevin equation a stochastic partial differential equation, are meant to account for 
the neglected degrees of freedom (e.g., from all the H2O molecules).  The two terms are linked via the fluctuation-
dissipation theorem of statistical physics [122, 85] and, because they are both thermal (statistical) in nature, they 
offer a route to controlling the temperature of a simulation system by adjusting the frictional and collisional coef-
ficients.  This is useful because, for instance, many biological simulations are performed in constant-temperature 
ensembles such as 𝑁𝑃𝑇 or 𝑁𝑉𝑇 [123, 124].  The limit of zero frictional coefficient corresponds to purely ‘inertial’ 
(Newtonian) dynamics, wherein solvent effects are neglected and the Langevin equation reduces to Newton’s 
second law.  Reciprocally, in the ‘diffusive’ limit of large frictional coefficients, the LD formulation corresponds 
to more ‘random’ motion and yields Brownian dynamics. 
3.5.3. Sampling and ergodicity 
Sampling tasks are exacerbated by two features of energy surfaces: (i) their vast dimensionality and (ii) their 
finely nuanced topography, featuring many peaks, valleys, and ridges of greatly varying magnitudes.  These two 
problems are interrelated.  Problem (i) means that the degree of computational sampling will be quite limited, 
making it all the more important to sample the most relevant regions of this space; here, ‘relevant’ is in the sense 
of low-energy regions, which contribute proportionately more to the equilibrium ensemble average as per their 
Boltzmann weights.  The sampling limitation has motivated the development of ‘importance sampling’, ‘en-
hanced sampling’ approaches, and a host of related algorithms (reviewed in [71]). Obstacle (ii) means that, in 
practice, a simulation may get ‘stuck’ in a low-lying region of the energy surface, with insufficient thermal inertia 
to surmount local energy barriers.  In such cases, novel or biologically relevant conformational transitions may be 
completely missed, or sampled an insufficient number of times to enable statistically significant calculation of 
dynamical properties (lifetimes, mean first passage times, etc.).  A general principle for sampling a physical quan-
tity, 𝑄, which fluctuates with characteristic time 𝜏𝑄, is that the dynamics should be sampled for at least a decade 
longer than the correlation time [104]; i.e., the simulation length should exceed 10𝜏𝑄 if statistically reliable aver-
ages are desired.  For these reasons, extensive sampling is crucial in MD simulations of biomolecular systems, 
where interesting transitions often occur on timescales that are quite slow relative to simpler molecular systems. 
Getting stuck in a region of conformational space also violates a fundamental axiom of statistical mechanics: 
bulk/ensemble properties are calculated from a distribution (Boltzmann or otherwise) under the assumption that 
the sampled points are representative of the system’s phase space. If we fail to sample any system configurations 
that are energetically low-lying ― and therefore non-negligible contributors to the ensemble average ― then the 
computed thermodynamic properties will not mirror the true properties of the system.  If, however, a simulation 
does not get trapped, we are left with a useful result: since the system can explore all of phase space, the distribu-
tion of conformations along a simulation trajectory for just one particle will be indistinguishable from the distri-
bution for a solution of many particles at one instant. This is the ergodic axiom: all accessible microstates are vis-
ited, subject to some p.d.f. that defines the system, in the limit of infinite time/sufficient sampling. Alternatively, 
the time average of an observable, 𝑨, for a single particle (denoted 𝑨) equals the ensemble average of that quanti-
ty (denoted 〈𝑨〉) for a macroscopically large set of those particles [85], as expressed below: 
                                              𝑨 = lim𝜏→∞ 1𝜏 ∫ d𝑡𝑨�𝒑𝑁(𝑡),𝒓𝑁(𝑡)�𝜏𝑡=0  
                                                         ⇕ 
                                          〈𝑨〉 = ∫⋯∫d𝒑𝑁d𝒓𝑁𝑨(𝒑𝑁,𝒓𝑁)𝝆(𝒑𝑁,𝒓𝑁)    (4) 
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In these equations, 𝑡 and 𝜏 indicate time; 𝒓𝑁 and 𝒑𝑁 are generalized coordinates and momenta of each particle as 
a function of the 𝑁 degrees of freedom (6𝑁-dimensional integral over all DoF); and 𝝆 denotes the equilibrium 
phase space probability density function, given, for example, by Eq 2. 
 
4. Molecular dynamics simulations 
The motivation for MD simulations is manifold, and includes studies of protein function (e.g., dynamical basis of 
allostery [99, 125]), protein malfunction (e.g., effect of point mutations that alter the intrinsic catalytic efficiency 
of an enzyme in metabolic diseases [126, 127]), the mechanism of protein self-assembly into fibrils and other pol-
ymers in neurodegenerative diseases [128], nucleic acid conformational transitions [129], the dynamical basis of 
specific (and non-specific) protein∙∙∙nucleic acid recognition [130], the dynamical features of the binding of drug 
compounds or small-molecule ligands to receptors [131, 16], and other types of molecular recognition events.  An 
overview of the MD method is given in Box 3 and Fig 5. 
4.1. Why simulation as a route to dynamics? 
MD simulations are just that – simulations – because many of the timescales relevant to the biological functions 
of proteins and nucleic acids (Fig 2) are experimentally inaccessible.  The functional dynamics of a biopolymer 
modulate its intra– and inter–molecular interactions and are of great physiological importance. For instance, an 
enzyme’s ‘breathing’ motions may permit substrates to diffuse into its active site and subsequently re-organize 
into a productive substrate–enzyme complex [132].  The thermal fluctuations mediating these and other bio-
molecular recognition events can range from large-scale domain rearrangements and binding/unbinding events to 
much smaller-scale changes (e.g., redistribution of rotameric states of the conserved side-chains lining an active 
site).  In addition to this example of enzymes, detailed molecular dynamics are what govern the inter-atomic in-
teractions occurring as ligands approach their cognate binding sites, such as in the binding of agonists or antago-
nists to receptors [133].  There are two key aspects of a molecule’s dynamics to consider: The characteristic time– 
and length–scales that describe the frequency and spatial extent of the motion [7]. As described in §3.3, large-
scale motions are intrinsically complex and can occur as combinations of many fundamental modes, harmonic or 
otherwise; such motional modes are referred to as the collective modes that mediate rare events.  The difficulty of 
accessing such dynamics via experimental approaches is what motivates modern MD-based simulations. 
4.2. Overview and justification of the method 
By an MD trajectory we mean a list of positions and momenta of each particle in a system over time, as the sys-
tem samples its phase space (Fig 3). The complexity of even a simple biomolecular system – in terms of the num-
ber of particles, degrees of freedom, and potential interactions – prevents us from analytically solving for such 
dynamics using the equations of classical mechanics.  Instead, we compute trajectories by approximating the 
equations of motion via numerical integration: the instantaneous force acting on each particle 𝑖 is calculated, 
𝐹𝚤��⃗ = −∇𝒰𝑖, the forces are used to compute accelerations, and the accelerations are used to update particle veloci-
ties and positions.  Is this valid?  Is it reasonable to perform classical MD simulations (versus quantum dynamics) 
of protein-sized entities?  Does our dynamics method need to treat both the electrons and atomic nuclei? 
These questions can be addressed by considering two approximations rooted in the physics of molecular sys-
tems: the thermal de Broglie wavelength and the Born-Oppenheimer approximation. The thermal de Broglie 
wavelength (Λ) for a particle of mass 𝑚 is given by Λ = ℎ �2𝜋𝑚𝑘B𝑇⁄ , where ℎ is the Planck constant, 𝑘B the 
Boltzmann constant, and 𝑇 the absolute temperature.  Of most importance is the value of Λ relative to the mean 
inter-particle separation in the system, 〈𝑟𝑖,𝑗〉.  For length-scales on which Λ ≪ 〈𝑟𝑖,𝑗〉, particle interactions can be 
approximated as classical rather than quantum mechanical [85].  Thus, while the dynamics of light atoms (e.g., 
mass of hydrogen) at low temperatures (𝑇 ≈ 0) would require quantum mechanical treatment, classical dynamics 
is a valid approximation for protein-sized entities at typical temperatures of interest in biology (≈ 300 K).  As for 
the electronic components of the molecular dynamics, we can neglect these and treat only nuclear motions be-
cause of the Born-Oppenheimer approximation [8].  This principle results from the fact that electrons are so much 
lighter than nuclei that the electron density ‘moves’ (in response to a force) two orders of magnitude more quickly 
than do the nuclei.  Thus, we can view atoms in a protein as consisting of electron clouds that respond virtually 
instantaneously to shifts in nuclear positions; more formally, the quantum mechanical wavefunction, which de-
scribes the full dynamics of the system, is separable and can be factorized into nuclear and electronic components, 
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given by a pair of Schrödinger equations.  In this way, the electronic degrees of freedom are essentially absorbed 
into the effective interatomic potentials (i.e., force-fields) used in classical MD simulations. 
Any MD-based methodology relies on two essential components, one physicochemical (force-fields; §4.3) 
and one algorithmic (integrators; §4.4).  Regardless of the above issue of classical versus quantum dynamics, the 
core problem in MD — integrating the equations of motion — simply requires a set of forces with which to up-
date atomic positions.  The algorithm is agnostic about the source of the forces, which can come from ab initio 
quantum mechanical calculations or, as is done in classical MD simulations, by computing force as the gradient of 
an empirical force-field (below).  Note that while the nuclear motions are treated classically, the interatomic forc-
es and electronic structure still can be evaluated quantum mechanically at any desired time-step in the trajectory.  
Though beyond the scope of this article, hybrid quantum mechanics/molecular mechanics (QM/MM) and ab ini-
tio MD approaches are essential in order to model processes wherein the electronic structure of a molecule is al-
tered, such as the covalent bond transformations that may occur in enzyme catalysis [8, 134]. 
4.3. Force-fields and the potential energy surface 
A force-field (FF) encapsulates all that we believe to be important about the physicochemical properties (§3.2) of 
the atomic interactions that govern molecular structure & dynamics.  As illustrated in Fig 4, the FF expresses mo-
lecular interactions quantitatively, using equations, free parameters, and estimates of parameter values.  Macro-
molecular FFs, also known as potentials, originated in molecular mechanics efforts of the late 1960s [135].  Those 
efforts were aimed at calculating primarily structural and stereochemical properties of small organic molecules — 
conformational strain, geometry optimization, etc.  In principle, computing the FF energy as a function of 3D 
structure, for all possible 3D conformations, would provide the complete potential energy surface of a molecule. 
The two defining features of a FF are its general functional form and the precise numerical values it assigns to 
the constant parameters in its equations.  Many FF implementations derive from the following general equation, 
which gives the potential energy, 𝒰(𝒓�⃗ 𝑖), as a function of position for each atom 𝑖.  In this classic MM approach, 
covalent interactions are taken as summations over 1–2, 1–3, and 1–4 bonded terms, while non-bonded interac-
tions are modeled pairwise, as sums over Lennard-Jones and Coulombic potentials: 
𝒰(𝒓�⃗ 𝑖)  = � 𝑘𝑖𝑟(𝑟 − 𝑟0)2
𝑏𝑜𝑛𝑑𝑠
  + � 𝑘𝑖𝜃(𝜃 − 𝜃0)2
𝑎𝑛𝑔𝑙𝑒𝑠
   + � 𝑘𝑖𝜑[1 + cos(𝑛𝑖𝜑𝑖 − 𝛿𝑖)]
𝑡𝑜𝑟𝑠𝑖𝑜𝑛𝑠
 
+��4𝜀𝑖𝑗 ��𝜎𝑖𝑗𝑟𝑖𝑗�12 − �𝜎𝑖𝑗𝑟𝑖𝑗�6�
𝑗≠𝑖𝑖�������������������
𝐿𝑒𝑛𝑛𝑎𝑟𝑑−𝐽𝑜𝑛𝑒𝑠 12−6 𝑝𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙
     +   ��𝑞𝑖𝑞𝑗
ϵ𝑟𝑖𝑗𝑗≠𝑖𝑖�������
𝐶𝑜𝑢𝑙𝑜𝑚𝑏𝑖𝑐 𝑡𝑒𝑟𝑚
       (5) 
The FF parameters, which may number well into the hundreds, list all the spring constants (𝑘), reference bond 
lengths (𝑟0) and angles (𝜃0), torsional angles (𝜑), multiplicities (𝑛) and phases (𝛿), Lennard-Jones parameters (𝜀, 
𝜎), and partial charges (𝑞), contained in Eq 5, for all possible types of atoms and pairwise interactions encoun-
tered in typical biomolecular systems.  While bond lengths and angles are handled in a fairly straightforward and 
similar manner in different FFs, various biomolecular FFs treat torsional potentials and other terms in subtly dif-
ferent ways.  For instance, AMBER and OPLS use specific scaling factors for vdW or electrostatic interactions be-
tween 1–4 atoms [136], and some CHARMM FFs employ grid-based energy correction maps (‘CMAP’) for pro-
tein φ/ψ torsional barriers [41, 137].  Regardless of this variation, for all FFs a working set of values (a ‘parame-
ter set’) is obtained by optimally fitting the parameters, via linear or nonlinear regression, against libraries of tar-
get data [41].  These target data originate from two sources, either empirical measurements (e.g., from thermo-
chemistry, such as heats of vaporization, from structural databases, and so on) or ideal values obtained by QM 
calculations on small model compounds (charge distributions, torsional barrier heights and multiplicities, etc.).  
The model compounds are small enough for QM calculations at very high levels of theory, and the compounds 
chemically resemble the constituents of biopolymers – the alanine dipeptide, blocked amino acids, mono- and di-
nucleotides, etc.  For these reasons, the FFs used in MD simulations or docking are said to be parameterized, and 
are described as empirical force-fields.  Most modern FFs are transferable across related classes of compounds, 
but make assumptions such as pairwise additivity and the neglect of atomic polarizability (see Box 4 for these 
terms).  Because the FF defines a system’s internal energy, the accuracy of a simulation is ultimately limited by 
that of its FF.  Approximations are necessary to make simulations feasible, and the simple functional form of typ-
ical FF equations represents a compromise between accuracy and computational tractability.  For more infor-
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mation, lucid accounts of FFs can be found in refs. [41, 138, 42, 43, 139, 140, 44], including reviews of available 
FFs (AMBER, CHARMM, etc.) and their applicability to various classes of biomolecules. (Virtually all modern 
FFs are applicable to polypeptides, but some have been more finely tuned than others towards nucleic acids, car-
bohydrates, or lipids.) 
4.4. Integrating the equations of motion and computing a trajectory 
The integrator is the core of any MD-based simulation method (Fig 5). The basic algorithm is the following: giv-
en atomic positions and velocities at time 𝑡, compute the force on each atom from the negative gradient of the en-
ergy; from classical mechanics, these forces yield the acceleration of each atom (?⃗? = 𝑚?⃗?) which, in turn, is used 
to numerically integrate the equations of motion and update the coordinates and velocities, bringing us to time 
𝑡 + 𝛿𝑡. In this way, the system dynamics are propagated from 𝑡 → 𝑡 + 𝛿𝑡 to yield the MD trajectory (in general, 
𝛿𝑡 ≈ 1 fs).  Recall that potential energy is determined by the 3D structural coordinates, in conjunction with the 
FF; kinetic energy is computed from atomic velocities, using Eq 9 in §4.7.2.  In principle, each of a system’s 𝑁 
atoms could interact with any other atom via bonded or non-bonded interactions, if not at time 𝑡 then possibly at 
another time.  Therefore, assuming the overall problem can be decomposed into pairwise interactions, and absent 
any simplifying numerical assumptions or algorithmic tricks, the computational complexity of the core MD calcu-
lation scales as 𝒪(𝑁2); this ‘inner loop’ over pairwise interactions is the main bottleneck in MD codes, as elabo-
rated below and in refs [141, 104, 81, 142].  In practice, the scaling can be improved to 𝒪(𝑁 log𝑁) via cutoff 
schemes, particle-mesh Ewald methods, and other approaches described in §4.5. 
 Because the equations of motion cannot be integrated analytically, many algorithms have been developed for 
numerical integration by discretizing time (𝛿𝑡) and applying a finite difference integration scheme [143]; text-
books on differential equations can be consulted for the mathematical bases of these methods (e.g., [144]).  MD 
integrators differ in their balance between numerical efficiency (greater number of simplifying assumptions) and 
accuracy (fewer assumptions), and the closely related issue of robustness ― How sensitive is trajectory stability 
to timestep 𝛿𝑡?  Using a larger 𝛿𝑡 would yield a longer trajectory, but the larger timestep also may render the dy-
namics unstable, with energies diverging, the protein structure ‘exploding’, etc.  To demystify MD integrators 
(black box in Fig 5A), the remainder of this section sketches a simple derivation of the ‘leapfrog’ method (Fig 
5C). 
To derive the leapfrog integrator, begin by considering the location, given by the position vector 𝐫, of a parti-
cle at time 𝑡.  Express the position 𝐫, velocity 𝐯 (first time-derivative of position, also denoted by a single 
prime 𝐫′), acceleration 𝐚 (second derivative), and all higher-order derivatives of the particle dynamics (𝐫(𝑛)), as 
Taylor series expansions in 𝛿𝑡, thereby arriving at the following set of equations: 
 r(t + δt) = r(𝑡) + 𝛿𝑡v(𝑡) + 1
2
𝛿𝑡2a(𝑡) + 1
3!𝛿𝑡3r′′′(𝑡) +  ⋯ (6a) 
      v(t + δt) = v(𝑡) + 𝛿𝑡a(𝑡) + 1
2
𝛿𝑡2r′′′(𝑡) + 1
3!𝛿𝑡3𝐫(4)(𝑡) +  ⋯ (6b) 
           a(t + δt) = a(𝑡) + 𝛿𝑡r′′′(𝑡) + 1
2
𝛿𝑡2𝐫(4)(𝑡) + 1
3!𝛿𝑡3𝐫(5)(𝑡) + ⋯ (6c) 
Relative to the 𝐫, 𝐯, and 𝐚 leading terms, the products with higher-order derivatives can be taken as ≈ 0 because 
of the (𝛿𝑡)𝑛 coefficients; similarly, equations with third- and higher-order leading terms are not shown above.  
Truncation of the above series at the third-order derivatives (i.e., all terms higher than acceleration) gives the set 
of familiar kinematics equations, such as the result that the velocity at time 𝑡 + 𝛿𝑡 can be computed from the posi-
tions at the start and finish of a [𝑡, 𝑡 + 𝛿𝑡] time interval: 𝐯(𝑡) = (𝐫(𝑡 + 𝛿𝑡) − 𝐫(𝑡)) 𝛿𝑡⁄  (indeed, this is the definition 
of the derivative, in the limit as 𝛿𝑡 → 0).  Now, recall from calculus that the mean value theorem ensures that for 
any differentiable function 𝑓 there exists some point 𝑏, in a closed interval [𝑎, 𝑐] from the domain of 𝑓, at which 
the derivative 𝑓′ equals the average value of the slope across the entire interval (note that this mean value, the 
slope at point 𝑏, corresponds to the slope of the secant line passing through 𝑎 and 𝑐).  In other words, there exists 
some point 𝑏 ∈ [𝑎, 𝑐]  such that 𝑓′(𝑏) = (𝑓(𝑐) − 𝑓(𝑎))/(𝑐 − 𝑎) holds true.  Application of the mean value theorem 
to the third-order truncated form of the foregoing Taylor expansions of the position 𝐫(𝑡) and velocity 𝐯(𝑡) estab-
lishes the two halves of the leap-frog integrator equations (Fig 5C).  Note from the leap-frog equations that a 
slight computational inconvenience of this algorithm is that the position and velocity updates are offset by half a 
step, 𝛿𝑡 2⁄  (Fig 5C); this inconvenience becomes asymptotically negligible as we approach the number of integra-
tion steps typical in biomolecular simulation (for 𝛿𝑡 = 1 fs, a 50-ns trajectory takes 5 × 107 integration steps).  
The ‘order’ of an integrator, denoted using big-O notation as 𝒪(𝑁) for order 𝑁, is the highest-order term in the 
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above series expansion which is included in the calculation (i.e., it denotes the level of approximation).  Because 
leap-frog equations neglect derivatives of order three and higher, this integrator is said to be a second order meth-
od [104].  Many further issues concern the application of integrators in MD, such as trajectory stability (robust-
ness of the integrator), multiple time-stepping schemes, time reversibility, suitability of the integrator equations 
for simulating dynamics in various ensembles and constraint schemes (freezing-out fast motional modes, such as 
sub-fs vibration of X–H bonds, enables larger timesteps).  These and related topics are discussed in many simula-
tion and modeling texts, including those by Leach [8], Schlick [10], Haile [104], and Allen & Tildesley [141].  
Also, Frenkel [145] and others (e.g., [146]) have recently presented some of the potential pitfalls inherent to simu-
lation studies. 
4.5. Optimizing the integrator 
The evaluation of bonded terms in the system Hamiltonian is straightforward.  The integrator maintains a list of 
all bonded interactions in the system, known from the covalent structure, and, at each timestep, evaluates these 
energies.  Bonded interactions correspond to bond distances, angles, and dihedrals, and therefore are also known 
as 1–2, 1–3, and 1–4 terms.  Since the number of bonded interactions grows as 𝒪(𝑁) for 𝑁 particles, the evalua-
tion of bonded energy terms is also 𝒪(𝑁).  (In classical MD, bonds are not altered and the electronic structure of 
the molecule is preserved.)  Non-bonded forces are more expensive to calculate because there are many more of 
them: Both vdW and electrostatic interactions occur between all pairs of atoms, and for 𝑁 atoms there are 
𝑁(𝑁 − 1) 2⁄  such pairs.  Therefore, naïve algorithms for non-bonded forces would scale as 𝒪(𝑁2) [81]. 
To optimize the non-bonded vdW force evaluation, a cutoff radius is chosen, typically near 10 Å.  All pair-
wise interactions exceeding the cutoff radius are assumed to be negligible.  A side-effect of this method is a dis-
continuity in energy as atoms cross the cutoff distance, which creates an infinite spike in the energy gradient and 
therefore an infinite force; such a scenario leads to system instability [81] and lack of energy conservation.  
Smoothing functions alleviate this problem by removing the discontinuity; specifically, forces are evaluated using 
the vdW potential up to a ‘switching distance’ (often ≈9 Å), and the vdW potential is smoothly decreased to a 
value of zero at the ≈10 Å cutoff (see, e.g., the NAMD user guide for a technical discussion [147]).  Though this 
algorithm makes 𝒪(𝑁) energy evaluations, it still must make 𝒪(𝑁2) distance evaluations — the distance to each 
other atom must be checked against the cutoff distance. To avoid this bottleneck, nonbonded ‘pair-lists’ are used 
to track which atoms may be within the cutoff.  A pair-list distance (≈12 Å) is chosen, and each atom keeps a rec-
ord of which other atoms were within this distance.  Then, during the evaluation of vdW energies, only atoms in 
the pair-list are considered.  After multiple time-steps, pair-lists are updated to account for atoms that may have 
moved in/out of the distance limit; these updates must occur often enough that no atom moves from outside of the 
pair-list distance to inside the cutoff distance before a regeneration cycle. Though regenerating the pair lists is 
𝒪(𝑁2), it occurs only infrequently, and can be further reduced to 𝒪(𝑁) using cells, as described below [142]. 
Electrostatic interactions decay less rapidly than vdW interactions, so using a simple cutoff scheme to define 
the set of necessary force calculations would require a very large cutoff.  Instead, the electrostatic interaction for 
the simulation system and all its periodic images (an infinite crystal) is generally treated using the particle-mesh 
Ewald (PME) approach, which decomposes the electrostatic energy into two parts: a short-range component that 
is evaluated with high accuracy, and a long-range component that is approximated via discretization of charges on 
a grid and calculations of reciprocal-space structure factors using this mesh.  The short-range component is evalu-
ated in real (or ‘direct’) space in much the same way as the vdW energy described above, and therefore goes as 
𝒪(𝑁).  The long-range component is generally evaluated using Ewald sums in Fourier (or ‘reciprocal’) space, us-
ing the fast Fourier transform (FFT) for calculation of structure factors and spline-based interpolation of the recip-
rocal-space sum [148].  FFT calculations scale as 𝒪(𝑁 log𝑁), so the overall scaling of the popular PME algorithm 
is also 𝒪(𝑁 log𝑁) [149].  A detailed description of the PME method is beyond the scope of this work; further in-
formation can be found in refs [148, 8]. 
Computationally expensive MD simulations are frequently performed on distributed-memory supercomput-
ers.  In a distributed-memory supercomputer, a set of independent computers are connected by a high-speed net-
work, and each computer is responsible for simulating some regions of the overall system.  Each region periodi-
cally informs its neighbors about the movement of its atoms.  If the regions are larger (in every direction) than the 
cutoff distance, then each region needs to communicate only with its 26 neighbors [142].  Since most communica-
tion occurs between neighboring regions (some global communication is necessary for electrostatics and monitor-
ing), atomistic MD codes such as NAMD [142] can scale to hundreds of thousands of processors with systems 
consisting of tens of millions of atoms [150].  Other available MD codes for biomolecular systems include popu-
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lar, long-standing software suites such as AMBER [136], CHARMM [151], GROMACS [152] and LAMMPS [153], 
newer packages such as DESMOND [154] and TINKER [155], and a host of other programs [156]. 
4.6. Some practicalities: From theory to practice 
Beyond the integrator, many practical questions must be considered in preparing to simulate.  The first stage of 
any simulation (system setup) is to prepare the molecular system, which includes the biomolecular solute and any 
solvent, ion, ligand, etc. molecules.  The components of a ‘simulation system’ are defined in Fig 5A and its cap-
tion.  Simulations are typically performed in the 𝑁𝑉𝑇 or 𝑁𝑃𝑇 ensemble in order to mimic experimental conditions 
as closely as possible.  Periodic boundary conditions (Fig 5B) help avoid surface effects (i.e., mimic bulk sol-
vent), though of course real solution-phase systems are not loosely packed crystals; as mentioned above, long-
range electrostatics are handled in periodic systems via Ewald sums [157].  Suitable system setup also requires 
one to consider (i) many chemical details (protonation states of ionizable residues, ionic strength, etc.); (ii) which 
force-fields to use (plural, if comparative analyses are being undertaken such as in [158] or [140]); (iii) addition of 
solvent molecules, and choice of water model [159]; (iv) decisions regarding non-bonded cutoff distances and 
switching functions; and, finally, (v) possible preliminary stages of energy minimization to relax the starting 
structure by relieving high-energy inter-atomic contacts (up to this point, the 3D structure of the biomolecule has 
not ‘seen’ the potential energy surface defined by the chosen FF).  Once these setup stages are complete, the MD 
system is subject to a brief heating and equilibration phase (often ≈ 1-5 ns), followed by a production phase of 
free dynamics, during which time atomic coordinates and velocities are written to disk every few ps.  Common 
practices in setting-up simulations are available in the literature for generic biomolecular systems [160, 124], nu-
cleic acids [161], and membrane proteins [162].  With modern computing power, production-length simulations 
are often ≈50-100 ns, and the longest are on the order of milliseconds [163, 69].  The exact duration depends on a 
balance of system size, compute resources, user patience, the timescale of the biochemical questions motivating 
the simulation (Fig 2) and, ultimately, how much sampling is required to achieve converged structural or dynam-
ical properties. 
Seemingly abstract simulation concepts can have very tangible consequences for how one proceeds in per-
forming an MD calculation.  These consequences are of practical concern to the user of a software package, and 
can be transparently understood in terms of basic principles.  For example, consider the role of cutoffs in all-atom 
MD simulations.  One is generally interested in the dynamical properties of a protein in bulk solution, not isolated 
in a nm-sized droplet of water, which would place the protein at a water/vacuum interface.  To avoid potentially 
artefactual surface effects, a protein is simulated under periodic boundary conditions (PBC; Fig 5). The PBC ge-
ometry is essentially a highly solvated crystal, packed loosely enough so that solute···solute interactions across 
cells are negligible (e.g., the DNA in Fig 5B and its periodic images).  An inherent geometric property of PBCs is 
that the so-called minimum image convention must be applied in order to avoid over-counting particle interactions 
(see the central cell and colored balls in the upper-right of Fig 5A) [141, 8].  This, in turn, demands the use of dis-
tance cutoffs for evaluation of non-bonded forces and long-range electrostatics.  As the final step in this chain of 
implications, note that the cutoff distance (𝑟𝑐𝑢𝑡) cannot exceed half the cell edge (for simplicity consider a cubic 
unit cell), lest pairwise interactions be double-counted.  The above line of reasoning is motivated by conceptual 
factors, such as the desire to simulate a biomolecule in bulk solution rather than at an air/water interface.  A sec-
ond, practical reason for using cutoffs, to lessen computational costs, was described in §4.5.  A cutoff distance 𝑟cut  
≈ 10-11 Å is generally used in biomolecular simulations, as a compromise between accurate evaluation of enough 
nonbonded forces (necessary for trajectory stability, energy conservation, etc.), versus excessive computational 
cost (the number of pairwise nonbonded forces to be evaluated scales as 𝑟cut3  [142]). 
4.7. Interpreting and assessing results 
4.7.1. Trajectory analysis via RMSD 
The raw data from a simulation is a list of coordinates 𝐫𝑖(𝑡) and velocities 𝐯𝑖(𝑡) as a function of time (𝑡) for each 
atom 𝑖.  That is the trajectory.  These data can be structured as a pair of two-dimensional arrays, 𝐑 and 𝐕.  Matrix 
𝐑 is built from the 3𝑁 Cartesian coordinates (𝑥,𝑦, 𝑧) for the 𝑁 atoms and, in the other dimension, is index by the 
simulation time 𝑡 (and similarly for the velocities, 𝐕).  Equivalently, a column vector of 𝐑 gives all the coordi-
nates for all atoms at one time-step, while a row vector gives the time series of a particular coordinate of one at-
om.  Coordinates are typically written every ≈1-2 ps, meaning that millions of snapshots are created in a μsec-
scale simulation.  What knowledge can be extracted from such dense data? 
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Simulation analyses can range from routine and straightforward to highly sophisticated, and can be either 
highly generic or more specialized to the type of system/question at hand.  An example of a generic type of tra-
jectory analysis, applicable to any system, is computation of the root-mean-square deviation (RMSD) of coordi-
nates over time.  Though the RMSD is not always an ideal metric for assessing equilibration and structural stabil-
ity [164], an RMSD analysis is performed early on (within the first few ns) in virtually all atomistic simulation 
studies [24, 160].  The RMSD for two coordinate sets, 𝐬𝑥 and 𝐬𝑦, is readily defined as: 
RMSD�𝐬𝑥 , 𝐬𝑦� = �∑ �𝑟𝐬𝑥,𝑖 − 𝑟𝐬𝑦,𝑖�2𝑁𝑖=1 𝑁  .         (7a) 
In this formula, 𝑟 is the vector of position coordinates for each of 𝑁 atoms, with each atom pair indexed by 𝑖; 𝐬𝑥 
and 𝐬𝑦 can, for example, be two frames in a trajectory (i.e., columns 𝑥 and 𝑦 of 𝐑).  Closely related, the root-
mean-square fluctuation (RMSF) of atom 𝑖, in a structure evolving over time, 𝐬(𝑡), can be formulated as: 
RMSF(𝐬(𝑡), 𝑖) = �∑ �𝑟𝐬,𝑖(𝑡𝑛) − 〈𝑟𝐬,𝑖〉�2𝑓𝑛=0
𝑓 + 1  ,         (7b) 
where now the summation is performed over all time-steps of interest (from 𝑛 = 0 → 𝑓), and 〈𝑟𝐬,𝑖〉 and 𝑟𝐬,𝑖(𝑡𝑛) are 
the time-averaged and instantaneous (𝑡𝑛) coordinates of atom 𝑖, respectively.  Slightly more sophisticated, one can 
compute two-dimensional matrices of pairwise RMSDs, thereby avoiding the issue of precisely which 3D struc-
tural snapshot should be taken as the reference point for the calculation (the starting structure?, after 1-ns of equi-
libration?, an averaged structure?, etc. [129]). 
4.7.2. Principal component analysis and related approaches 
As an example of a more sophisticated analysis approach, principal component analysis (PCA) can be used to cal-
culate the directions and amplitudes of greatest motion along a simulation trajectory.  PCA is a linear algebraic 
method of ‘dimensionality reduction’, meaning it can map datasets of high dimensionality — e.g., the vast vector 
space (𝕍) spanned by the 3𝑁 coordinates of a simulation system, sampled across millions of timesteps (the matrix 
𝐑 in §4.7.1) — into a new vector space (𝕍′), defined by an alternative basis set.  The key feature of the PCA ap-
proach is that this new, alternative basis set spans the bulk of the variation (literally, the statistical variance) that 
occurs in the original high-dimensional data, and it does so in a more informative manner than does the origi-
nal/naive basis set: We obtain a rank-ordering of the fraction of variance that is accounted for along each new 
basis vector, and the major directions of motion can be expressed as simple linear combinations of the new basis 
vectors (also known as principal component vectors, as described below).  A major strength of PCA is that it is a 
non-parametric method for analyzing high-dimensional datasets, such as the many frames comprising an MD tra-
jectory.  PCA is free of heuristics, assumptions about dynamical modes, etc., and the PCA algorithm takes trajec-
tory data as its only input.  A fundamental limitation of PCA is that the 𝕍 → 𝕍′ mapping alluded to above is a lin-
ear transformation; therefore, subtle non-linear correlations will be missed, such as correlated motion along circu-
lar paths (see the ‘Ferris wheel’ example in [165]).  PCA captures only that underlying structure of the data that is 
expressible as linear correlations. 
Useful introductions to PCA are available, from both general (e.g., [166, 165]) and MD-specific (e.g., [167]) 
perspectives.  In brief, consider a trajectory comprised of 𝑚 frames, for a simulation system of 𝑁 atoms.  Begin 
by removing the six rigid-body translational and rotational degrees of freedom of the molecule via least-squares 
structural superimposition of each frame to a reference (e.g., the initial structure).  Then, construct a 3𝑁 × 𝑚 ma-
trix, 𝐑, from the 3𝑁 Cartesian coordinates at frames 1, 2, … ,𝑚.  In this matrix, column 𝑗 is the vector of all atomic 
coordinates at frame 𝑗.  PCA is then achieved by (i) using 𝐑 to construct the variance-covariance matrix, 𝐂, of 3D 
coordinate displacements 𝑟 (versus trajectory-averaged mean coordinates, 〈𝑟〉), and then (ii) diagonalizing 𝐂 to 
obtain the principal components of the motion, denoted 𝑝𝑖, as projections onto the eigenvectors of this covariance 
matrix [168, 169].  These two steps correspond to the following pair of equations: 
𝐂 = 〈𝐑𝐑T〉 = 〈(𝑟(𝑡) − 〈𝑟〉)(𝑟(𝑡) − 〈𝑟〉)T〉 ,      (8a) 
𝐂 = 𝐘𝚲𝐘T ,      (8b) 
where 𝐘 is the orthogonal transformation that we seek to discover to diagonalize 𝐂, 𝚲 is a diagonal matrix contain-
ing the corresponding eigenvalues (λ’s), and a superscript ‘T’ denotes the transpose.  Note that 𝐂 is a symmetric 
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3𝑁 × 3𝑁 matrix, from which the linear cross-correlation matrix is obtained simply by normalizing each element 
𝑐𝑖,𝑗 by the factor (𝑐𝑖,𝑖𝑐𝑗,𝑗)1 2⁄ ; viewed this way, the diagonal elements of 𝐂 are the mean-square atomic fluctuations, 
〈|Δ𝑟𝚤�⃗ |2〉, that appear in §4.7.3 below.  The columns of 𝐘 are the eigenvectors of 𝐂.  The original trajectory coordi-
nates, 𝐑, can be projected onto these eigenvectors, 𝑢�⃗ 𝑖, in order to visualize the motion along each of those direc-
tions; doing so gives the corresponding 𝑝𝑖 principal components.  Notably, the eigenvectors 𝑢�⃗ 𝑖 are sorted in de-
creasing order of their corresponding eigenvalues, λ𝑖. Thus, eigenvector 𝑢�⃗ 1 is the direction along which the great-
est motion occurs – i.e., the direction that accounts for the largest fraction of variance in atomic positions across 
the dataset.  The corresponding eigenvalues give the statistical variance along each mode – i.e., the amplitude of 
motion, measured as mean-square displacements.  For proteins, an empirical finding is that the first several 𝑢�⃗ 𝑖’s 
account for much of the variance in atomic positions, at least on relatively short timescales where the assumption 
of linearity is unlikely to break down; for this reason, PCA is also known as ‘essential dynamics’ [168].  High-
amplitude vectors, which correspond to low-frequency modes in the harmonic approximation, are often taken as 
being functionally important dynamical modes; for instance, a ‘hinge’ between two protein secondary structural 
elements, about a specific direction given by principal component 𝑢�⃗ 𝑖, and with a particular magnitude (λ𝑖), may 
elucidate the dynamical basis for ‘gating’ of an active site.  As a further step, one may pursue clustering of protein 
conformers in the reduced dimensionality space of the first few principal components (the 𝕍′ space, above), rather 
than in the original Cartesian basis; such approaches can be used to compare the ‘essential subspaces’ of the dy-
namics of different proteins, assess trajectory equilibration, etc.  Finally, note that PCA is closely related to other 
eigenvalue decomposition approaches, such as normal mode analysis (NMA) and quasi-harmonic analysis 
(QHA).  For example, mass-weighting the terms in the covariance matrix gives the QHA approach which, in turn, 
can be used to estimate the conformational entropy from an MD trajectory [170-172]. 
In addition to a PCA decomposition of the trajectory, other quantities can be computed by relying on statisti-
cal mechanics as the link between raw trajectories (dynamics) and bulk thermodynamic observables.  For exam-
ple, one can compute the velocity autocorrelation function from a trajectory as an estimate of the diffusion coeffi-
cient [141]; similarly, other trajectory-derived correlation functions can be calculated and compared to experimen-
tally characterized transport coefficients.  As another example of the experiment ↔ simulation ↔ theory link, the 
radial distribution function (RDF) is a versatile theoretical concept that can be computed from trajectories and 
used in connection with both theory and experiment.  As the name implies, an RDF gives the distribution of parti-
cles, or number density, in a simulation system as a function of radial distance (i.e., isotropically averaged) from a 
reference particle, averaged again over all relevant reference particles.  This equilibrium quantity also can be 
viewed as the distribution of all distances between all pairs of particles (a spatial pair correlation function), and it 
is therefore deeply related to the time-averaged structure of a system of particles.  In this way, the RDF directly 
links to experimentally measurable quantities that report on inter-particle separations, such as solution scattering 
profiles obtained by small-angle X-ray scattering (SAXS) [173, 174].  An MD trajectory provides all coordinates 
(structures) at every time-point of interest, meaning one can use a trajectory to compute any desired RDF [104] – 
between all oxygen atoms in water, between a particular set of ions and a particular base in RNA [175], etc. –  for 
joint analysis with experimental scattering data.  That is the experiment ↔ simulation link.  As an example of the 
other direction (simulation ↔ theory), the RDF is intimately related to the statistical mechanical potential of mean 
force (PMF; [85]), and to the use of the PMF concept to justify the derivation of pairwise statistical (knowledge-
based) potentials from databases of known 3D structures [176, 177].  Thus, simulation-derived RDFs can also 
facilitate the testing of theoretical models and approaches. 
4.7.3. Reliability, validation, and relative strengths of the simulation approach 
Simulations can be viewed as more predictive than conclusive.  This is true of any purely computational approach 
and, indeed, any method taken in isolation (experimental or computational).  What simulations lack in certainty, 
versus a set of carefully-controlled biochemical experiments, they make up for by being the only widely available 
approach that can provide high resolution information about the dynamics of virtually any biomolecular system, 
in both space (atomic-resolution) and time (sub-ps time resolution).  The ‘validity’ of a given MD trajectory part-
ly depends on the exact biological question being considered (was the system simulated long enough?), as well as 
a host of potential technical concerns.  These technical issues are numerous and are often system-specific; the re-
mainder of this subsection is limited to a few illustrative points. 
Catastrophic errors often manifest themselves early in a trajectory, and often can be readily identified.  For in-
stance, the PME approach to long-range electrostatics can be sensitive to electroneutrality of the simulation sys-
tem: if the simulation cell contains excess electric charge because counter-ions were not added, then lattice sums 
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will diverge to infinity.  In practice, whether or not this problem occurs depends on the capabilities of the MD 
software and its default configuration settings.  For instance, non-neutral cells are auto-detected by many MD 
codes and a uniform ‘neutralizing plasma’ is applied as another term in the Ewald sum; inclusion/exclusion of 
this term is akin to the crystallographic ?⃗?000 structure factor, the amplitude of which is the number of electrons per 
unit cell, but which is an arbitrary additive constant in typical electron density map calculations.  Errors in con-
structing a PBC cell can result in atoms unfavorably interacting with other image atoms, yielding energy diver-
gence and trajectory instability.  Finally, simulations are also susceptible to less severe (but also more subtle) er-
rors, such as the possibility of periodicity-induced artefacts for the PBC simulations that are customary in bio-
molecular MD [178]. 
Efforts to ensure a reliable, or at least stable, trajectory must be made in the earliest stages of system selection 
and preparation (protonation, addition of ions, solvation, etc.), before the lengthy production phase commences 
[24, 160, 124].  Successful equilibration is vital, at least to the extent possible [146], and can be judged in terms of 
both structural stability and conservation of thermodynamic quantities.  Structural stabilization of a trajectory can 
be assessed by monitoring properties such as secondary structural content, by visual inspection in a molecular 
graphics suite such as VMD [179], and by plotting quantities such as the radius of gyration or RMSD to see that 
the system has not unfolded or dissociated (in the case of a supramolecular assembly).  For thermodynamic equi-
libration, those bulk properties that are expected to be conserved for the particular ensemble being used should 
reach stable values, generally within the first few hundred ps of simulation; bulk quantities will fluctuate, but 
should show no systematic drift.  For instance, in addition to conservation of total system energy, one would ex-
pect temperature stability for simulations in an isothermal ensemble such as 𝑁𝑃𝑇.  In practice, temperature can be 
monitored via an instantaneous ‘kinetic temperature’, 𝑇𝑘.  This quantity can be computed at timestep 𝑡 from a tra-
jectory’s atomic velocities by using the equipartition principle and the definition of kinetic energy in terms of par-
ticle velocities [141]: 
𝑇𝑘(𝑡) = 1𝑁𝑓𝑘B� |𝑝𝚤���⃗ (𝑡)|𝑚𝑖𝑁𝑖=1  ,           (9) 
where 𝑖 indexes all 𝑁 particles of momentum 𝑝 and mass 𝑚, and the other symbols are as used above.  The 𝑁𝑓 in 
the denominator of the prefactor is the number of degrees of freedom.  This term may equal 3𝑁 for the compo-
nents of velocity for a monoatomic particle in three dimensions or, for example, 3𝑁 −𝑁𝑐 if 𝑁𝑐 internal constraints 
are applied; the exact details depend on the exact dynamical system and simulation protocol.  Averaging over 
many MD time-steps yields 𝑇 = 〈𝑇𝑘(𝑡)〉 as the thermodynamic temperature. 
The question of sufficient sampling – how long to run a simulation – is difficult, as it depends on balancing 
computational cost against the exact meaning of ‘sufficient’.  As noted above, meaningful precision can be at-
tained with a ten-fold excess of data [104]; however, one may be unsure as to the characteristic timescale for a 
process of interest (e.g., a conformational transition).  Assessment of simulation accuracy is yet more difficult, 
largely due to the limited experimental options for cross-validation.  As an example of the type of data that may 
be used for cross-validation, trajectory-derived root-mean-square fluctuations (RMSF) for each residue in a pro-
tein can be compared to patterns of variability from NMR order parameters (S2) [180] or the B-factors obtained 
from refinement against X-ray diffraction data [181, 182].  The B-factor, also known as the Debye-Waller factor 
[183], quantifies the attenuation of X-ray scattering intensity (𝐼(ℎ�⃗ )) for each peak in a diffraction pattern.  Ex-
pressed in reciprocal (diffraction) space, with ℎ�⃗  denoting the vector of Miller indices ℎ,𝑘, 𝑙 for each Bragg reflec-
tion, we have: 
𝐼𝑒𝑥𝑝�ℎ�⃗ � = 𝐼0�ℎ�⃗ �𝑒−2𝐵(sin2𝜃 λ2⁄ ) .           (10) 
In this equation, 𝐼𝑒𝑥𝑝 is the measured experimental intensity, 𝐼0 is that for the ideal (frozen) lattice with no thermal 
vibration, 𝐵 is the overall temperature factor, and the sin2𝜃 λ2⁄  term captures the standard decrease in the magni-
tude of atomic form factors with increasing Bragg angle (𝜃) for a given X-ray wavelength (λ).  Alternatively, in-
dividual B-factors can be expressed in terms of individual/atomic motion, in real space, as follows: 
𝐵𝑖 = 83𝜋2〈|Δ𝑟𝚤�⃗ |2〉 ,           (11) 
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where 〈⋯ 〉 denotes the ensemble average and 〈|Δ𝑟𝚤�⃗ |2〉 is the mean square coordinate displacement of atom 𝑖 about 
its equilibrium position.  These equations, which take B-factors as scalars, assume isotropic atomic displacements; 
given sufficiently high-resolution diffraction data, full anisotropic B-factor tensors can be used to better resolve 
the atomic displacements [183].  Equations 10 and 11 link an experimental observable, namely X-ray reflection 
intensities, and a simulation-derived quantity, the RMSF along the trajectory (Eq 7b in §4.7.1).  However, in at-
tempting to validate a simulation by corroborating MD-derived RMSFs to patterns of variation in crystallographic 
B-factors (high B-factors in loops, active site residues, etc.), one should note two issues: (i) the typical B-factor 
refinement approach assumes isotropic and harmonic thermal motion, and (ii) the B-factor values generally com-
puted in macromolecular X-ray refinement implicitly include a host of additional, non-dynamical effects.  Issue 
(ii) is important because the mean atomic displacement of a specific residue in a macromolecular crystal arises 
from the authentic intramolecular dynamics of that residue, but also includes effects of static disorder and micro-
scopic heterogeneity (slight conformational variability in each unit cell), lattice imperfections and vibrations, and 
so on.  Because both static and dynamic phenomena contribute to the attenuation of X-ray reflection intensities, 
care must be taken when interpreting B-factors in terms of specific dynamical processes. 
Beyond the above issues, two main factors limit the precision and accuracy of simulations.  Firstly, the ap-
proximations inherent in force-fields, and the MM approach itself, restrict the accuracy of trajectory-derived val-
ues, as alluded to in §4.2–3.  Secondly, the necessarily limited sampling means that trajectory-derived numerical 
averages may be insufficiently converged, there could be many conformational transitions that occur in nature but 
go unobserved in a limited-length trajectory, and so on.  These two limitations – force-fields and statistical sam-
pling – have motivated many areas of contemporary MD research.  For instance, much recent work has been de-
voted to creating polarizable force-fields [184, 185], more efficient ab initio and hybrid QM/MM approaches 
[134], enhanced sampling techniques [71], and so on.  A thorough discussion of the relative merits of various 
MD-based approaches can be found in [47]. 
4.8. Simulations in structural biology 
In addition to the utility of simulations in analyzing biomolecular dynamics and function (e.g., allostery), MD-
based methods are used in biology to determine the 3D structures that serve as starting points for such analyses.  
Perhaps nowhere has the practical impact of MD been greater than in experimental structural biology, which is 
largely concerned with determining structures via X-ray crystallography or NMR spectroscopy.  To illustrate the 
power of leveraging MD with experiment, consider the role of simulating annealing refinement.  MD-based simu-
lated annealing is generally used in the refinement of both crystallographic models [186] and in NMR structure 
determination [187].  Simulated annealing refinement works by using MD as a conformational search tool: An 
artificial energy landscape is constructed by adding a fictitious energy term to the FF, to penalize discrepancies 
with diffraction data.  Using MD, this landscape is initially sampled at exceedingly high (physically unrealistic) 
temperatures, thereby providing the system — in this case, the trial 3D structural model — with enough thermal 
energy to cross local energy barriers.  Several stages of short dynamics runs are performed, with the system tem-
perature lowered at each stage according to a prescribed cooling schedule. The power of this approach is that it 
generates successively better (lower energy) structures as the simulation stages proceed at sequentially lower tem-
peratures, thereby refining the 3D structure. Further details of this MD approach and its utility in crystallography 
have been reviewed [75]. 
This fruitful application of simulating annealing to structural biology illustrates a general principle: Because 
of their generality, simulation-based approaches offer flexible frameworks for handling experimental data (to get 
to a 3D structure), integrating various types of data, and then extracting knowledge that is inaccessible from such 
data alone (e.g., dynamics of the 3D structure). An example of the synergistic application of computation and ex-
periment is the determination of a structural model for the nuclear pore complex (NPC), an ≈ 50-100 MDa assem-
bly of hundreds of proteins and lipids (reviewed in [1]).  In the NPC work, many lines of experimental data were 
taken as distance restraints and cast as energy terms in a molecular mechanics framework [188].  This approach 
enabled the application of energy minimization and simulated annealing routines to obtain a collection of struc-
tures most compatible with the combined set of experimental data (or least incompatible, in the sense of a cost 
function). The success of the approach hinged on two facts: (i) electron microscopy, chemical cross-linking, mass 
spectrometry, and virtually any other source of low-resolution data facilitates structure determination [1] by con-
straining the allowed 3D structures, and (ii) computational methods, such as the simulation-based methods of this 
text, provide a way to sample the space of possible solutions, via rapid generation and evaluation of trial struc-
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tures.  Thus, computational methods provide a natural framework for the development and implementation of 
‘hybrid’ approaches for difficult/low-resolution structure determination. 
 
5. Computational docking as a means to explore molecular interactions 
Because of the pivotal roles of molecular dynamics and interactions in vivo, many computational approaches have 
arisen to model and elucidate these interactions in silico.  The many different types of molecules (proteins, nucleic 
acids, small molecules, etc.) found inside even the simplest of cells means that an even far greater number of con-
ceivable types of interactions can occur in cellular physiology [5].  Such interactions are often pairwise, A•B, 
where if A = B (and the constituents are protein) the interaction is termed homotypic (e.g., homo-oligomers such 
as an ATPase), whereas for A ≠ B the interaction is called heterotypic (e.g., a hetero-dimer protein, oxygen bound 
to hemoglobin).  Most generally, the interaction partners A and B may be protein, nucleic acid, carbohydrate, li-
pid, or any of a number of other small molecules and ions (the heme ring in hemoglobin, ATP-binding sites, etc.). 
The binary A•B complex may be short– or long–lived with respect to the lifetime of the cell, and the A•B associa-
tion may be thermodynamically quite stable (e.g., cytoskeletal polymers [189]) or only marginally so (e.g., en-
trapment of a polypeptide in the GroEL cage for folding and release [190]).  Finally, in addition to binary interac-
tions, ternary and higher-order contacts can occur, giving rise to intricate homo- or hetero-oligomeric complexes 
and, in some instances, open-ended polymeric structures such as the cytoskeletal ‘scaffolding’ proteins. 
5.1. Physical chemistry of molecular associations 
Apart from the role of macromolecular crowding [2] in promoting interactions between any two random mole-
cules A and B, note that a specific A•B complex will form only once the entities A and B are within suitable dis-
tance for energetically favorable inter-atomic interactions to occur, denoted by A···B.  What is meant by ‘suitable 
distance’?  Recall from §2 and §3 that non-covalent forces originate in the laws of physics, and are of only a few 
fundamental varieties: relatively long-range electrostatics (𝒰𝑒𝑙𝑒𝑐  ~ 1 𝑟⁄ ), shorter-range hydrogen-bonding interac-
tions (fundamentally electrostatic, requires chemically complementary donor and acceptor), and even shorter 
range vdW interactions (features attractive and repulsive components).  In addition, solvation and other entropic 
effects play a major role in molecular interactions [191-193]; these effects include the entropy-driven free energy 
changes due to solvent reorganization and differential exposure of hydrophobic patches near the A•B interface. In 
computing the affinity of an A···B contact, note that a possibly delicate balance of entropic effects is at play: Tak-
ing A and B as rigid bodies, six rotational and translational degrees of freedom are lost upon formation of the 
complex (∆𝑆A•B𝑜 < 0, disfavoring association), while the entropy change of solvent molecules liberated from the 
A•B interface (∆𝑆𝑠𝑜𝑙𝑣𝑜 ) will favor association. In one common approach, the magnitude of ∆𝑆𝑠𝑜𝑙𝑣𝑜  is taken to be 
proportional to the solvent-accessible surface area that becomes occluded in the A•B interface [194].  Though far 
from straightforward, properly accounting for these subtle entropic effects is necessary for accurate calculations 
of ligand-binding free energies [89, 107, 45]. 
Formation of an initial A···B ‘encounter complex’ occurs via the diffusional association of A and B, followed 
by possible smaller–scale intermolecular interactions and intra-molecular rearrangements (induced fit) that finely 
tune the stability of the complex. An alternative model of ligand-binding mechanics is conformational selection 
[195-197], wherein the ligand B binds favorably to a particular subset of conformers of A, ‘selected’ from the full 
ensemble of thermally-accessible states of A under the given conditions.  Features of both the induced fit and con-
formational selection models are likely to occur in many ligand-binding reactions [198].  For both models, the 
molecular interactions are precisely the sorts of nonbonded forces listed above and in §3.2, and are what one at-
tempts to correctly capture for accurate protein–ligand docking.  Hydrodynamics and its associated methods, such 
as Brownian dynamics simulations, provides the theoretical and computational framework for studies of diffu-
sional association and dissociation of A···B over cellular length-scales (≈ tens of nm) and timescales (μs → ms) 
[199, 119].  These length and time regimes generally exceed what is possible, in terms of both algorithmic 
frameworks and computational resources, for studying the fine-grained (atomic-level) details of A···B interactions 
— for instance, elucidating specific hydrogen bonds between a patch of conserved amino acids on A and a struc-
turally complementary region of B, the open ↔ close dynamics of a hydrophobic trench on the surface of A, etc.  
These two problems of (i) long-distance, long-time diffusional association of A and B, and (ii) short-distance, 
short-time details of interactions between A and B (and molecular dynamics of the resultant A•B complex) are 
essentially handled as separate issues in current computational studies, rather than treated in an integrated manner.  
The remainder of this section focuses on methods to study P···L and P···P interactions, where one entity is pro-
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tein (P; also termed the receptor) and the other component may be a small-molecule compound known as the lig-
and (L). 
In principle, the computational approaches developed to treat receptor···ligand interactions can be generally 
applied to any A···B system, be it protein···protein, protein···nucleic acid, nucleic acid···ligand, etc.  In practice, 
the variations between these types of interactions enable different sets of approximations and methods to be ap-
plied to each.  As with force-fields and molecular mechanics, the calculations are numerically intensive, and sim-
plifying estimations are necessary to render the calculations feasible.  For instance, crude treatment of magnesium 
ions is unlikely to degrade the overall results of a protein–ligand docking pipeline, as magnesium plays a relative-
ly rare role in mediating such interactions in proteins; however, deficiencies in modeling Mg2+ would adversely 
affect RNA–ligand docking, as many such interactions are magnesium-mediated (polyvalent ions are a weakness 
in typical all-atom classical MD simulations with non-polarizable FFs [200]).  Because protein···ligand and pro-
tein···protein docking have been the most thoroughly studied, the remainder of this section focuses on these two 
types of molecular interactions. 
5.2. Protein–ligand docking 
5.2.1. General goals 
Unlike the usage of MD to study the conformational dynamics of a protein, the general goal of most protein–
ligand docking efforts is not to simulate the binding process as it occurs in nature (a notable exception is ref [16]). 
Rather, the aim is to predict and characterize possible molecular complexes in terms of the 3D structure of the 
ligand-binding site and the ligand itself (the pose), and possibly the ligand-binding energetics as well [89].  (The 
standard state Gibbs free energy of binding is a measure of equilibrium binding affinity via the usual relationship 
Δ𝐺bind𝑜 = −𝑅𝑇 ln𝐾𝐷.)  After an initial round of docking studies, one may wish to carefully dissect the enthalpic 
and entropic components of binding, ∆𝐺𝑏𝑖𝑛𝑑𝑜 = ∆𝐻𝑜 − 𝑇∆𝑆𝑜, in order to use such information to guide and refine 
the ligand design process.  For instance, decreasing the number of rotatable (single) bonds in a candidate inhibitor 
compound will reduce its entropy loss upon binding, thus enhancing the overall binding affinity (all other things 
being equal) [201]. 
5.2.2. More specific goals 
In planning a docking study, the precise objectives must be carefully considered, as these goals dictate the allow-
able approximations in the scoring method and the necessary amount of sampling. Three scenarios can be envis-
aged.  (1) Is the goal to exhaustively characterize the binding of a single compound L across the surface of a pro-
tein Ƥ?  If so, then extensive sampling across the entire protein surface must be performed (‘blind-docking’ as-
sumes no knowledge of the location of potential ligand-binding sites), with moderate approximations necessary 
for the scoring function [202].  (2) Is the goal virtual screening (Box 5) of large databases of compounds against 
protein Ƥ? If so, then the degree of sampling will be necessarily quite limited and more aggressive approaches for 
rapidly generating trial configurations, such as genetic algorithms or Monte Carlo, must be employed, versus 
more physically realistic (but costly) approaches such as MD simulation [203].  Similarly, in this scenario a rapid-
ly computable, heuristic scoring function would be preferable to a more accurate, but costly, physics-based FF.  
(3) Is the goal to predict the activity of a family of related small molecules (say Ļ, Ľ, Ł, Ḽ), at a particular binding 
site, in order to assess their value as potential lead compounds for drug development? This would require calcula-
tion of accurate binding free energies to protein Ƥ (Δ𝐺𝑏𝑖𝑛𝑑𝑜  for Ƥ•Ļ, Ƥ•Ľ, Ƥ•Ł, etc.).  Similarly, a related goal 
might be to predict the effects of point mutants of Ƥ, either engineered or naturally occurring, on the binding af-
finities for this set of compounds. This third scenario is the most computationally demanding, as accurate ligand-
binding free energy calculations require extensive configurational sampling and an accurate FF representation of 
the physical interactions ([204] and references therein). 
5.2.3. Basic principles, approaches 
Docking consists of two parts: (i) a sampling method to general trial P•L structures (poses) and (ii) a scoring sys-
tem to evaluate a pose by assigning it a value that presumably reflects its accuracy.  Note that this is analogous to 
the basic approach in MD simulations, where the equations of motion serve as a sampling method (propagate the 
equations forward in time) and the FF serves the role of a scoring function.  The task of sampling is also referred 
to as the ‘search’ problem in docking.  The aim of accurate scoring is related to the goal of computing ligand-
binding affinities.  Modern docking research is dedicated largely to the sampling and scoring problems [110].  
While many effective methodologies have been developed, many limitations continue to hamper the usage of 
docking in computer-assisted drug design (CADD) pipelines, in terms of efficiency (coverage – largely an issue of 
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sampling) and reliability (accuracy – largely an issue of scoring functions).  Further information on docking prin-
ciples and approaches, including lists of software suites, have been reviewed in several places ([205-208, 77]).  
After outlining the demands on a docking method, the remainder of this subsection elaborates the two problems of 
sampling and scoring. 
The demands — How we approach the sampling and scoring problems, e.g. what level of approximation is per-
missible, is dictated by the demands we make of a docking method for a specific application.  For instance, the 
docking method used in a CADD pipeline will necessarily be cruder (computationally cheaper, per compound) 
than the techniques used in a careful study of binding energetics (using, for instance, free-energy perturbation cal-
culations on a small set of ligand compounds).  The demands of most docking applications occupy one of three 
levels: (i) At the crudest level, a docking study may simply aim to identify active ligands from a library of candi-
date compounds, even if the predicted P•L structure for that compound is incorrect or there are minor inaccuracies 
in the pose.  Here, ‘active’ is taken to mean high-affinity binding (sub-μM), though in principle it simply means 
bio-active, irrespective of in vitro binding strength. In this context, experimental binding data from high-
throughput screening can help cross-validate docking results, thereby improving the overall accuracy of the dock-
ing study. (ii) At a more demanding level, the docking approach will identify the ‘true’ ligand by discriminating it 
from a pool of inactive compounds and will also correctly predict the pose of this ligand in the binding site.  At 
this level, crystallographic or NMR structures of the P•L complex (or a close analog P•L′) provide a means of val-
idation that can also be used to refine the ligand design.  (iii) At the highest level of stringency, a docking method 
will successfully identify true binders, correctly predict the P•L structure, and accurately estimate Δ𝐺𝑏𝑖𝑛𝑑𝑜 .  At pre-
sent, this level (iii) is not computationally feasible as part of a high-throughput pipeline because accurate free en-
ergy calculations require both extensive configurational sampling and an accurate scoring system, in the form of a 
physics-based FF that can account for binding-associated changes in entropy of the ligand and receptor, solvation 
effects, and so on [207]. 
Sampling — A docking search method is used to sample configurational space as efficiently as possible, thereby 
generating many P•L structures for scoring and ranking.  To achieve this, three sets of issues must be considered: 
(i) the sampling algorithm, (ii) how molecular flexibility is treated, and (iii) whether the docking will be blind 
(unknown binding site) or focused on a particular region of the receptor (a known or suspected binding site).  The 
challenge is clearly much greater in blind versus focused docking: As shown in Fig 6, a blind docking study must 
consider the entire solvent-accessible surface of the receptor in order to avoid false negatives, whereas in focused 
docking more extensive sampling, and therefore better docking, is possible because the same computational re-
sources can be focused on a more limited spatial domain (finer grids, more exhaustive sampling of trial poses, cf. 
Fig 6A and B).  In the absence of high-resolution structural information, lower-resolution experimental data, such 
as from chemical cross-linking, can greatly aid a docking study by enabling a focused calculation instead of blind 
docking.  Determining the site for a focused docking study can be accomplished manually or by more automated 
methods, including MD simulations of the target protein with small probe molecules to identify binding sites 
[203]. 
Of the four possibilities for treating ligand and protein flexibility, {L, P}×{flexible, rigid}, virtually all cur-
rent software suites treat the small-molecule L as flexible (rotatable single bonds), while some packages allow for 
partial inclusion of protein flexibility [77], e.g. by considering only a subset of residues centered near the pre-
sumptive binding site (the yellow receptor side-chains in Fig 6B).  Given today’s computing power and docking 
algorithms, what can be achieved lies between the two extremes: a rigid-L/rigid-P treatment is unnecessarily 
crude and inaccurate, but flexible-L/flexible-P is not yet routinely feasible (in the sense of a fully flexible protein, 
including all side-chains and backbone). 
The type of sampling algorithm (issue i) and the treatment of flexibility (issue ii) are closely intertwined.  
Docking codes typically take one of three approaches to sampling: (a) systematic, (b) stochastic, or (c) simula-
tion-based.  Systematic methods pursue a brute-force calculation, wherein the geometric parameters of interest are 
systematically varied across all possible values of those DoFs.  For example, if we are interested in torsion angles 
1, 2, and 5 of L, then we might sample each of those torsion angles across the full angular range in increments of 5°.  Even this unrealistically simple case yields (360 5⁄ )3 = 373, 248 combinations of parameter values to evalu-
ate in the scoring function. Moreover, the previous figure severely underestimates the true number of potentially 
important degrees of freedom: 3 translational and 3 rotational DoF describe the rigid-body location and orienta-
tion of L with respect to P (these must be sampled with some reasonable granularity), and the number of torsional 
DoF in P dwarfs the above estimate for L.  This combinatorial explosion in the dimensionality of the search space 
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grows geometrically with the number of DoF and severely limits the general effectiveness of systematic sampling 
approaches.  For these reasons, most docking codes utilize stochastic search methods such as Monte Carlo sam-
pling, genetic algorithms, or ‘tabu’ search (these methods are described in [209, 206, 207]). An example of a sim-
ulation-based strategy would be to use MD-based simulated annealing to generate trial poses; an advantage of 
simulation approaches is that they offer a natural way to incorporate molecular flexibility in the docking calcula-
tion, but a disadvantage is the computational cost required for atomistic simulations to cross high-energy barriers 
and achieve reasonable sampling.  Because of the difficulties of the search problem, many alternative sampling 
strategies have evolved.  Most of these schemes incorporate a stochastic or simulation-based algorithm as a cen-
tral routine.  Examples for sampling the space of possible ligands/poses include incremental ‘fragment-growth’ 
methods [210] and database methods (libraries of pre-generated conformers that can be manipulated [211]).  Ex-
amples of alternative approaches to treat receptor dynamics include the usage of protein side-chain rotamer librar-
ies, protein ensemble grids, and so on (see reviews cited above). 
Scoring — Reliable docking calculations require a robust scoring system, wherein numerical values are assigned 
to each of the candidate P•L complexes generated by the sampling algorithm. These numerical values (or ‘scores’) 
are often assumed to correspond to Δ𝐺𝑏𝑖𝑛𝑑𝑜  values, even when such scores are more knowledge-based rather than 
physics-based.  Early docking codes [212] assigned scores based on geometric fit/steric complementarity between 
P and L; such an approach successfully captures the essence of apolar interactions (and therefore works with hy-
drophobic ligands), but neglects potentially important effects such as electrostatic complementarity and the do-
nor/acceptor directionality of H-bonds [201].  As described in the remainder of this section, modern scoring sys-
tems are either (i) FF–based, (ii) empirically-derived functions, or (iii) knowledge-based. 
Force-field–based scores adopt the MM approach (§3.2, §4.3), with physically motivated terms to model the 
energetics of inter-atomic contacts between P∙∙∙L.  In fact, many FF-based scoring systems used in docking stem 
from the transferable FFs developed over the years for MD simulations (AMBER, CHARMM, etc.).  While a dis-
advantage of the FF-based scoring systems is that they are computationally costly, versus the other two types of 
scoring approaches, an advantage is that their physical basis permits one to manipulate the terms in a comprehen-
sible manner; for instance, one can ‘soften’ atomic interactions by adjusting the repulsive wall of the Lennard-
Jones potential from 𝑟−12 to 𝑟−9. 
The other two types of scoring systems, empirical and knowledge-based, are both statistical in nature. Empiri-
cal scoring systems utilize simpler functional forms than in the FF approach, with parameters that are obtained by 
fitting against experimentally determined binding affinities [213].  A strength of this approach is that its simpler 
functional forms are computationally cheaper to evaluate; a drawback is that the nonbonded interaction terms, 
because they are derived by statistical regression, could be physically rather ad hoc (they may not be transferable 
to other classes of ligands, the terms in the equation may be difficult to troubleshoot as they do not correspond to 
physicochemical properties, and so on).  Also, as with many statistical fitting approaches, the parameters of the 
scoring system can be inadvertently over-trained against the necessarily limited datasets from which they are de-
rived, thus limiting the transferability of the scoring approach [214, 215]. 
Knowledge-based scores derive an effective energy for an interatomic interaction A∙∙∙B by computing the sta-
tistical occurrence of this interaction (e.g., frequency of A∙∙∙B pairs) in a large database of known 3D structures. 
Implicit in this approach, which is based on the concept of a PMF (§4.7.2), is the assumption that all of the phys-
ics that might be relevant to an A∙∙∙B interaction is implicitly contained as pairwise interactions in our databases of 
known 3D structures [216, 217].  As is the case with empirical scores, knowledge-based scores are rapidly evalu-
ated because of their simple functional forms and limited number of terms.  In addition to the issue of transferabil-
ity and other caveats about statistical potentials, more subtle drawbacks to the knowledge-based approach include 
its basis in the concept of a reference state for the PMF (the reference state is a clear idea in the thermodynamics 
of simple systems, but a less clear concept when counting pairwise A∙∙∙B interactions in a macromolecular com-
plex).  To make the calculation of scores numerically tractable, the scoring functions of the statistical potential are 
evaluated on a spatially discretized grid.  That is, the ligand is positioned at successive points on a user-defined 
grid, possibly with sub-Å spacing between grid points (Fig 6).  Docking codes achieve run-time efficiency by pre-
computing these ‘atomic affinity grids’, which specify, for each unique atom type, the interaction between that 
atom and other atom types (such as may occur in the ligand).  Such grids are computed for the various non-
bonded components of the potential energy (e.g., Coulombic, vdW), and accelerate the overall calculation by ob-
viating the need to re-compute the grid for each successive translation of the ligand across the grid [207]. 
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The three scoring methodologies described above ― FF-based, empirically-derived, and knowledge-based 
potentials ― serve as a starting point for several strategies to enable more accurate scoring and ranking of docked 
poses.  For instance, the core idea in the ‘consensus scoring’ approach is to combine for a single docking calcula-
tion the results obtained by application of different scoring schemes, parameters settings, etc., thus providing a 
consensus score for each pose. If the underlying inaccuracies of each scoring system are statistically independent 
of one another (a major assumption), then any such errors would cancel and the consensus score should serve as a 
more accurate predictor by which to rank poses in terms of binding affinities. In the ‘re-scoring’ strategy [218, 
219], the results from an initial docking calculation (i.e., the poses, rank-ordered by score) are refined by re-
scoring the list of poses using a higher-accuracy (more costly) scoring scheme, such as the MMPBSA approach. 
The MMPBSA approach addresses the three chief shortcomings of most scoring systems – entropies, solvation, 
and electrostatics – by using a molecular mechanics-based approach to estimate conformational entropies (MM), a 
continuum treatment of electrostatics via the Poisson-Boltzmann equation (PB), and surface area terms (SA) to 
capture solvation effects [220]. 
5.2.4. Software packages 
The key idea in docking is to rapidly generate many P•L trial structures and then evaluate each candidate using 
scoring functions such as those described above.  Most of the variation between different docking packages stems 
from differences in how they address the sampling and scoring problems. The first general-purpose protein–ligand 
docking code (DOCK) was developed by Kuntz and coworkers at UCSF and released in the late 1970s [221].  In 
the intervening thirty years, a multitude of approaches have been developed and implemented as software suites 
that are either freely or commercially available. Because many heuristic approximations, empirical optimizations 
(parameter-tuning), and other computational ‘shortcuts’ enter these packages to make the calculations feasible, 
there can be great variation in the performance of different programs for different types of problems (e.g., blind 
versus focused docking), and with respect to different performance metrics. For example, a major performance 
criterion, in terms of sampling, is the treatment of flexibility.  Virtually all modern software packages treat ligands 
as flexible, but until recently only few codes incorporated even partial receptor flexibility as a way to better sam-
ple the space of possible protein–ligand binding modes [77].  Because software packages rapidly evolve and algo-
rithms are under continual development, the set of available docking codes, and their speed, accuracy and other 
performance metrics, are fast moving targets.  Software suites are not listed here, as compilations of some of the 
most prevalent docking codes are available in the literature.  For example, Kitchen et al. [206] and Sousa et al. 
[207] provide tables of docking programs, with the codes categorized by sampling approach, scoring methodolo-
gy, handling of receptor flexibility, and various other criteria. 
5.3. Protein–protein docking 
Most cellular processes are mediated by protein-based assemblies [222, 5, 223], such as protein folding chaper-
ones [224], polymeric components that form cytoskeletons [225], and ribonucleoproteins such as the ribosome 
[115].  For simplicity, consider only protein–protein interactions, and specifically the case of homotypic interac-
tions of a protein ‘Ƥ’ that assembles into oligomers of n subunits, Ƥn.  The monomer, Ƥ, may be non-functional, 
partly functional, or it may exhibit some unique, alternative function (apart from Ƥn).  In any case, the precise bio-
chemical function of Ƥ, such as binding a specific ligand signal, may be similar or dissimilar to the physiological 
function of the full oligomer in vivo; if Ƥ and Ƥn have similar biochemical properties, then the oligomer may 
simply act by presenting multiple interaction sites (a concept termed avidity).  Most often for self-associating pro-
teins, the biologically functional unit is the oligomeric assembly; it is this assembly which supplies some vital 
biochemical function and is therefore the evolutionarily conserved entity [223]. In such assemblies, head → head 
association of subunits yields complexes that are generally closed, whereas interactions with head → tail polarity 
can give either closed (cyclic) assemblies or open-ended ‘runaway’ structures (polymeric fibrils in one dimension, 
sheets or layers in two dimensions, and crystals in three-dimensions [226]).  In all such cases, protein–protein 
docking can be applied. 
Assume we know from experiments that well-defined homomeric A•A or heteromeric A•B associations occur 
in vitro.  Such information is often accessible via analytical ultracentrifugation, FRET spectroscopy, or other solu-
tion-state biophysical approaches [227].  Then, protein docking can help further characterize these complexes by 
addressing basic questions: (i) Can a stable A•B complex be identified by the docking methods (plural, if trying a 
consensus docking approach)?  (ii) If so, how many such distinct A•B binding modes are there?  For example, are 
there two or three distinct binding patches, leading to various A•B geometries, or does a single geometry recur as 
the top hits in the docking trials?  (iii) What is the predicted binding affinity for the A•B complex?  How does this 
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value compare to that determined from, e.g., isothermal titration calorimetry or surface plasmon resonance meas-
urements?  Though not always straightforward, such questions can be addressed via protein docking.  Methods for 
protein docking have evolved in parallel with the protein–ligand field, albeit with a time-lag that is due, in part, to 
the relative scarcity of 3D structural data on protein–protein complexes versus protein–ligand complexes. Protein 
docking faces many of the same computational challenges as protein-ligand docking, with two specific types of 
problems taking on heightened significance in the protein-protein case: (i) protein flexibility should be treated, at 
least at the side-chain level, as numerous pairwise contacts between side chains define an A•B interface (the ener-
getics of the binding process is at least partly governed by the loss of conformational entropy of these side-
chains); (ii) the need to accurately model solvation becomes even more pronounced in protein docking, as desolv-
ation of the interface is a major determinant of the association mechanism. As with protein-ligand docking, many 
computational strategies have been developed to address these questions; this active field has been reviewed re-
cently [228, 215]. 
Protein–protein docking has taken on renewed relevance in this post-structural genomics era.  We now have 
3D structures of many of the isolated components of cellular complexes, but not the entire assemblies.  Many 
such assemblies are only transiently stable, making them recalcitrant to structure determination via X-ray crystal-
lography or NMR spectroscopy.  Efficacious protein–protein docking, along with protein–nucleic acid and pro-
tein–ligand docking, would provide a path towards predicting the structures of such complexes and thereby bridge 
the rapidly widening gap between our knowledge of individual protein structures and the cellular-scale structures 
into which they assemble. 
 
6. Conclusions 
The interior of a cell is crowded with biopolymers, molecular assemblies, and small molecules.  This dense envi-
ronment is a highly dynamic network of molecular contacts (Fig 1A), meaning that a full understanding of any 
cellular pathway requires an accurate and detailed description of the molecular dynamics within and between its 
components.  Though such interactions vary immensely in terms of possible types (chemical groups), strengths 
(thermodynamic stability), and lifetimes (kinetics), molecular simulations provide a powerful approach.  The 
atomic contacts that mediate the binding of a small-molecule inhibitor to an enzyme active site are of the same 
physical nature as the contacts that stitch together the dozens of subunits in a cellular-scale assembly such as the 
ribosome. The fundamental interactions are the same, only the chemical variety and number of pairwise (and 
higher-order) contacts differ; these differences in molecular recognition give rise to the variation we see in biolog-
ical assemblies.  The difficulties in experimentally characterizing the conformational dynamics of biomolecular 
assemblies have driven advances in simulation-based approaches, such as MD and docking.  The power of the 
simulation approach stems from its origin in statistical mechanics, which links the experimentally accessible mac-
roscopic properties of a system to the microscopic structure and dynamics of its constituents.  Indeed, the versatil-
ity of simulation-based approaches is immense, as molecular simulations have been applied to studies of (i) nor-
mal protein function (e.g., allostery), (ii) protein malfunction (aggregation diseases, mutations in metabolic dis-
eases, etc.), (iii) protein structure prediction, design and engineering (e.g., homology modeling), (iv) macromolec-
ular structure determination via crystallography, NMR and electron microscopy, and (v) structure-based drug de-
sign.  The utility and applicability of molecular simulations will only continue to grow with our increasing 
knowledge of biological systems as highly dynamic arrays of molecular interactions. 
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Side Boxes [Optimal location in the text is indicated.] 
 
Box 1: Notational conventions, abbreviations, symbols [located early, before §2] 
• Words or phrases are italicized either for emphasis or when introduced as new terminology; vectors are indicated 
either in bold italics (e.g., 𝒓 for the position vector) or by an arrow above the letter (e.g., 𝑟). 
• Abbreviations, acronyms, symbols: BD, Brownian dynamics; DoF, degree of freedom; FF, force-field; FFT, fast Fouri-
er transform; LD, Langevin dynamics; MC, Monte Carlo; MD, molecular dynamics; MM, molecular mechanics; NMA, 
normal mode analysis; PBC, periodic boundary conditions; PCA, principal component analysis; p.d.f., probability dis-
tribution function; PME, particle-mesh Ewald; PMF, potential of mean force; QM, quantum mechanics; RMSD/F, root-
mean-square deviation/fluctuation; a single center dot ‘•’ indicates an intermolecular complex and a triple ‘∙∙∙’ denotes 
specific interatomic interactions 
• The following symbols denote physical constants or frequently appearing quantities: 𝐸𝑡𝑜𝑡, total system energy; 𝒰, po-
tential energy (also written 𝐸𝑝𝑜𝑡 and known as the internal energy of a molecule); 𝒦 or 𝐸𝑘𝑖𝑛, kinetic energy; 𝑇, abso-
lute temperature (Kelvin); 𝑆, entropy; 𝐻, enthalpy (or Hamiltonian, ℋ, depending on context); 𝐴, Helmholtz free ener-
gy; 𝐺, Gibbs free energy; 𝑍, partition function; 𝑚, mass; 𝑁A, Avogadro constant (≈6.02×10
23 entities/mole); 𝑘B, Boltz-
mann constant (≈1.38×10−23 J/K) 
 
Box 2: Simulation-related physical concepts and terminology [located in §3 (Physical principles)] 
• Ensemble: A collection of 𝑁 particles possessing some well-defined, bulk thermodynamic properties, such as tem-
perature (𝑇), pressure (𝑃), or mean energy (𝐸); importantly, 𝑇, 𝑃, 𝐸, and all other macroscopic quantities become sta-
tistically well-defined, with only infinitesimal fluctuations about the mean, beyond ~105 particles. Three ensembles 
commonly used in MD simulations are 𝑁𝑉𝐸 (microcanonical), 𝑁𝑉𝑇 (canonical), and 𝑁𝑃𝑇 (isothermal–isobaric), which 
correspond to fixed numbers of particles, volume, energy, etc., as indicated by the symbols for each. These three en-
sembles correspond to maximizing the system entropy, minimizing the Helmholtz free energy (𝐴 = 𝒰 − 𝑇𝑆), or mini-
mizing the Gibbs free energy (𝐺 = 𝐻 − 𝑇𝑆), respectively. For some types of systems (e.g., an ion channel in a planar 
membrane bilayer), less common ensembles may become useful (e.g., the constant surface tension [𝛾] and normal 
pressure [𝑃⊥] ensemble, 𝑁𝑃⊥𝛾𝑇). 
• Phase space: For a dynamical system of N particles, this is the multidimensional space of all values of position (q; 3N 
DoF) and momenta (p; 3N DoF). Importantly, proteins and other systems of interest are well-defined collections of 
particles (there is a particular pattern of covalent connectivity that defines, say, a leucine versus an isoleucine), so 
not all arbitrary values and combinations (q, p) are allowed; also, particular regions of phase space are preferentially 
populated, and at equilibrium the Boltzmann distribution is the probability distribution function (p.d.f.) governing the 
population of these accessible regions of phase space. In short, phase space can be viewed as a hyper-dimensional 
inventory of all the potential microscopic states of a system together with the probability of occurrence of each; thus, 
as a concept phase space encompasses all that is knowable about the microscopic dynamics of a thermodynamic 
system. 
• Trajectory: The list of coordinates (𝑟𝑖) and velocities (𝑣𝑖) for each atom i in a system, as a function of time, over the 
course of a dynamics simulation. An individual structure from this time series {𝑟𝑖(𝑡)} is often referred to as a snapshot 
or frame from the trajectory. 
• Ergodicity: This central axiom of statistical mechanics is that the ensemble average of some observable property (A) 
of a system, denoted 〈𝐴〉, converges to the same value as the time-average of that property, denoted 𝐴, in the limit of 
infinite sampling. This is the fundamental justification for applications of MD, as it stipulates that trajectory-averaged 
properties computed for a single molecule in isolation (a simulation system) equals the bulk thermodynamic proper-
ties of the system. This is also why sufficient sampling is crucial in MD, where ‘sufficient’ means to the point of con-
vergence of bulk properties. 
 
Box 3: Overview of MD simulations [located in §4 (MD simulations)] 
• What is it? — A computational method to numerically evaluate the equations of motion for a set of particles, such as 
the atoms in a protein. The result is an MD trajectory, which is a detailed description of the dynamics of the system on 
the timescale of the simulation. 
• How is it done? — The equations of motion for such a complex system are not soluble, neither in principle (many-
body problem) nor in practice (analytically intractable to solve for dynamics of 6𝑁 degrees of freedom, where 𝑁 may 
exceed 103 non-hydrogen atoms in a small-sized protein). Instead, we discretize time and numerically integrate the 
equations of motion via a finite difference method: Given a set of initial positions (𝒓𝑖(𝑡𝑛)) and velocities (𝒗𝑖(𝑡𝑛)) for 
each particle i at step n (time 𝑡𝑛), compute the forces on each atom (from the gradients with respect to the force-field 
potential) to obtain accelerations. Next use the positions (𝒓𝑖), velocities (𝒗𝑖), and accelerations (𝒂𝑖) with the classical 
equations of motion to obtain updated positions and velocities for step 𝑛 + 1 (= time 𝑡𝑛 + 𝛿𝑡, where 𝛿𝑡 is the integra-
tion timestep, typically ~1-2 fs for biomolecular simulations). 
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Box 4: Concepts and terminology: Force-fields [located in §4 (MD simulations)] 
The following terminology often appears in connection with force-fields: 
• Additivity: If the forces and energetics of the interaction between two particles, A and B, are not influenced by the 
presence of a third particle, C, then the interaction is said to be additive; in this case, because we are considering 
pairs of particles, the forces are described as pairwise additive. 
• Polarizability: The susceptibility of the electronic distribution about an atomic nucleus to distortion by an external elec-
trical field, such as may arise from neighboring charged groups. This can be an important effect in highly-charged 
systems such as nucleic acids. Until recently, polarizability has been almost always neglected in MD force-fields and 
simulations, as its inclusion makes the MD calculation more costly. 
• Transferability: In FF development, this is the idea that the physicochemical parameters developed for so-called 
model compounds (e.g., a blocked alanine) can be transferred, without loss of validity or accuracy, to chemically re-
lated compounds (e.g., an alanine residue in a polypeptide); such parameters are typically derived via high-level QM 
calculations that are feasible only for small model compounds. The notion of transferability is fundamental to the de-
velopment of generalized force-fields. 
• Water model: The precise geometric structure (bond lengths, angles) and electronic structure (e.g., location and 
magnitude of partial charges) used to represent a H2O molecule, as well as the types of physical effects included in 
the treatment (e.g., polarizability). Several water models have been developed over the years (TIP3P, SPC, etc.); the 
main differences between them concern the number of ‘interaction sites’ (e.g. lone-pairs as dummy sites), how struc-
tural flexibility/rigidity is handled, and how water molecule polarizability is treated. 
 
Box 5: Concepts and terminology: Docking [located in §5 (docking)] 
The following terminology often appears in the docking literature: 
• CADD, SBDD: These acronyms are common in the docking literature, and denote computer-aided drug design and 
structure-based drug design; protein–ligand docking is a key step in most CADD workflows. A related concept is HTS 
(high-throughput screening), which may be performed experimentally (via robotic automation) or computationally (vir-
tual screening of candidate drug compounds or other small ligands via in silico protein–ligand docking pipelines). 
• Receptor/ligand: In a binary interaction, P•L, the larger entity (typically a protein or nucleic acid) is known as the re-
ceptor and the smaller molecule, such as a drug compound, is known as the ligand; analogous terms from chemistry 
are host (receptor) and guest (ligand). In drug-design applications, ligands that bind a receptor and elicit a positive 
response are known as agonists, whereas antagonists bind and inactivate receptors. 
• Pose: The geometry or binding mode of a ligand in a receptor binding/active site. The pose is precisely described via 
(i) the usual six DoF that specify the rigid-body location of the ligand in space (three translational + three orientational 
parameters, relative to the receptor), and (ii) the exact 3D structure (conformation) of the receptor-bound ligand, in 
terms of its internal DoF. Typically only torsion angles (1-4 interactions) for the ligand, and possibly for receptor resi-
dues lining the active site, need to be considered, as bond lengths and angles do not significantly deviate from their 
standard reference values at physiological temperatures. 
• Pharmacophore: A 3D model that defines, for a specific class of receptors, the important features of cognate ligands. 
Distinct chemical regions of the ligand are described in terms of physicochemical properties, including the relative 
contributions of each region and its associated properties to ligand-binding energetics and geometry. The develop-
ment of dynamical pharmacophores is a modern research direction that aims to transcend static models by account-
ing for ligand flexibility, thereby improving pharmacophore-based methods for drug discovery and modeling of dy-
namic molecular interactions. 
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Figure Captions 
 
Figure 1: Molecular interactions over many length-scales. Structural biology and molecular simulations have 
reached the point that atomically-detailed models can now be built for the bacterial cytoplasm, and dynamics in 
this crowded medium can be studied. A snapshot from such a simulation is shown in (A); as implied by this image 
(from [3]), a cell can be defined by its set of molecular interactions. Flexibility in the number (few, dozens, hun-
dreds) and types (polar, hydrophobic, etc.) of contacts yields immense variability in the resulting complexes.  For 
instance, panel (B) shows part of the structure of the bacterial ribosome (protein blue, RNA yellow) bound to the 
antibiotic chloramphenicol (vdW spheres near center).  This cellular-scale assembly is a vast network of pro-
tein···RNA (pink lines), protein···small-molecule (green lines) and protein···protein (not shown) contacts.  Of 
these, protein–ligand interactions are the simpler to treat (local length-scale, fewer contacts) and are also of major 
pharmaceutical relevance, as enzyme inhibitors and other drugs are often small organic compounds.  As an ex-
ample of such interactions, panel (C) shows the anticancer drug imatinib bound to the tyrosine kinase ABL2 (an 
oncoprotein associated with several cancers).  As is true of many ligand-binding sites, the compound binds in a 
concave, cleft-like region on the solvent-accessible protein surface [229].  The exact location of this binding site 
— between two protein domains (SH2 domain in gray, kinase domain in brown) — is related to imatinib’s inhibito-
ry potency (imatinib···ABL2 interactions block ABL2’s phosphorylation activity).  Myriad molecular interactions 
similar to the ones shown here are forming, persisting, or dissociating in a cell at any given moment. 
 
Figure 2: Biomolecular interactions and dynamics: Relevant timescales. Biomolecular structure is modulated 
by dynamical processes that span several decades, ranging from ps–scale side-chain rotations to much longer 
(≈μs) times for rigid-body translation and rotation of higher-order structural units.  Secondary structural elements, 
super-secondary structural elements (e.g., helix-turn-helix motif or a β-hairpin), or entire protein domains can en-
gage in ‘collective motions’ on even longer timescales. Though omitted from this schematic for clarity, distinct mo-
tional modes also occur in nucleic acids, such as ns–scale re-puckering of nucleoside sugar rings and the longer 
characteristic times for global twisting, stretching, and bending of duplex helices. The terminology often used to 
describe these dynamical regimes includes ultrafast (≤ fs), fast (~fs ↔ ~ps), infrequent (~ps ↔ ~ns), and intrinsi-
cally complicated (~μs ↔ ~ms) processes.  As a point of reference, the 𝛿𝑡~1-fs integration step used in most at-
omistic MD simulations is indicated. The approximate year in which simulations of a given duration (ps, ns, …) 
became at least feasible, if not routine, is shown above the timeline; for instance, μs-scale simulations became 
computationally attainable (multiple such simulations began appearing) shortly after 2005. 
 
Figure 3: Phase space and its sampling via MD and MC. (A) A diagram of phase space for the simple harmon-
ic oscillator, taken as a one-dimensional spring with a mass 𝑚 attached. This dynamical system is described by 
the potential 𝒰(𝑥) = −½𝑘(𝑥 − 𝑥0)2, where 𝑥 is the coordinate of the mass, 𝑥0 is its relaxed (equilibrium) position, 
and 𝑘 the spring constant (𝑘 ~ stiffness).  Differentiation of this equation yields the force 𝐹(𝑥) = −𝑘(𝑥 − 𝑥0), which 
we can analytically solve for the values of position and momenta as shown in (A); the position is labeled by a ‘𝑞’, 
rather than ‘𝑥,’ in panel (A) because ‘𝑞’ is often used to indicate a generalized coordinate in classical mechanics, 
and is the same as 𝑥 for the simple case of a one-dimensional harmonic oscillator.  Consistent with our intuitive 
notion of oscillatory motion of a spring, note that (i) the mass reaches a minimal velocity (=0) at the two ‘turning 
points’ of maximal and minimal compression of the spring ((𝑞, 𝑝) = [±𝑞𝑚𝑎𝑥, 0]), and (ii) this dynamical system trac-
es a repetitive orbit in phase space.  The phase space of a more complex dynamical system (e.g. a protein with N 
atoms) is inordinately more complicated – it consists of (𝑞, 𝑝)3𝑁−6 dimensions, and trajectories in this space may 
be irregular (not periodic). Exploring such a hyper-dimensional phase space requires some form of conformational 
sampling. Two well-established sampling approaches are MD simulations and Monte Carlo (MC).  What is the 
difference between these methods?  MD aims to simulate, with physical realism, the actual motion of the particles 
in a system; as described in §4, this is done by integrating the equations of motion to propagate the atomic coor-
dinates along a trajectory in the system’s phase space (𝑡1 → 𝑡2 → 𝑡3 ⋯ in (B)).  In contrast, MC proceeds as a se-
ries of discrete ‘trial moves’ (e.g., “flip torsion angle 42 by 180°”). The sequence of trial moves are independent of 
one another, and are accepted or rejected by comparison of the Boltzmann-weighted probability to a randomly 
generated number. Whereas MD is analogous to a game of connect-the-dots in phase space, MC can be thought 
of as skipping dot-to-dot in this hyper-dimensional space.  
 
Figure 4: Molecular interactions and force-fields, in context. The core elements of a molecular mechanics-
based FF, such as is used in MD simulations, are shown in the context of an important molecular interaction: the 
binding of the cancer therapeutic imatinib to ABL2 kinase (see Fig 1C). The overall structure of the ABL2•imatinib 
complex shows the location of the drug (ball-and-stick and semi-transparent vdW spheres); protein side-chains 
that interact at the binding site (ball-and-stick) are shown in atomic-level detail in panel (A). The atomic interac-
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tions between ABL2···imatinib (B) include polar contacts (yellow dashes) such as hydrogen bonds, interactions 
that are more strongly electrostatic in character (𝛿+ ⋯𝛿−), and numerous vdW interactions between non-polar 
groups of atoms (not shown for clarity).  The components of a typical FF are schematically drawn in (B), showing 
the roles of these inter-atomic interactions (bond angle bending, torsional rotations, etc.) in mediating the molecu-
lar recognition process.  In classical MD, the full potential energy (𝒰) is taken as a sum of various types of physi-
cochemical interactions (shown in (B)), and each type of interaction is treated explicitly via specific terms in the FF 
equation (see text, Eq 5).  The terms in Eq 5 account for (i) bond stretching (1-2 interactions), angle bending (1-3 
interactions) and torsion angle rotation, as well as (ii) non-bonded interactions between apolar groups (a Lennard-
Jones potential to model dispersive interactions). The short-range component of electrostatic interactions be-
tween fixed partial charges is modeled via Coulomb’s law, and long-range electrostatics across the PBC lattice 
are treated via Ewald summation. 
 
Figure 5: MD simulations in a nutshell. MD simulation is a multi-stage process that employs several chemical, 
physical, and computational principles (A). Working left → right in panel (A), a starting 3D structure is prepared by 
addition of solvent and other moieties, giving an initial list of atomic coordinates (time t0). These 3D positions, to-
gether with the covalent chemical structure of the molecule, define the molecular system (blue box). Literally all of 
the precise atomic details that define a complete, solvated biopolymer structure are contained in the chemical to-
pology file: the standard amino acids, nucleotides, common ions, the detailed patterns of covalent connectivity 
and the orders of bonds — which atoms are bonded to one another, various hybridizations (𝑠𝑝2, 𝑠𝑝3), whether an 
amine is 1°, 2°, and so on. Force-fields also include a parameter file associated with the topology file, defining the 
functional form of the potential energy equation (Fig 4B), as well as the reference values for bond lengths (𝑟0), 
angles (𝜃0), multiplicity and phase of torsional angles, Lennard-Jones parameters, and so on. Conceptually, the 
three parts of an MD simulation system (green box) are (i) the force-field (gray box; not system-specific); (ii) the 
atomic positions and velocities over time (which are system-specific, and which give the MD trajectory); and (iii) 
the key details that describe the simulation to be performed – which thermodynamic ensemble, whether periodic 
boundary conditions (B) are employed, cutoff lengths for evaluation of non-bonded interactions, and so on. Taking 
this system as input, the MD software (black box) computes the forces on each atom from the gradient of the po-
tential, −∇𝒰(𝑟). Newton’s second law relates these forces to the acceleration of each atom, 𝜕2𝑟 𝜕𝑡2⁄ , which, in 
turn, relates to the atomic position and velocity by classical mechanics (C). The MD engine generates a trajectory 
by discretizing time, often with an integration step 𝛿𝑡 ≈ 1 fs, and integrating the equations of motion.  To achieve 
this, the algorithm iterates over all inter-atomic interactions (bonded and nearby nonbonded pairs), computes the 
forces of atoms on one another, and then uses these forces to update the positions and velocities of each atom, 
via numerical methods such as the ‘leapfrog’ integrator (C; see §4.4). 
 
Figure 6: Protein–ligand docking in action: A computed grid. Many protein-ligand docking algorithms employ 
a discrete spatial grid over which the calculation is performed, as explicitly shown here. In this example, the re-
ceptor is the ABL2 tyrosine kinase and the ligand is the inhibitory compound imatinib (see also Fig 1C). Coarse 
grids were used for ‘blind’ docking over the entire receptor (A), while finer grids could be applied for more ‘fo-
cused’ docking centered on the (known) ligand-binding site (B).  Docking grids were computed using AUTODOCK, 
and the illustration was created and rendered in PyMOL. 
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Figure 2: Biomolecular interactions and dynamics: Relevant timescales
10-15sec 10-9 10-6
10-3
100
bond vi-
bration
allosteric transitionsrelative domain 
motions,
10-12
electronic structure 
changes; elementary 
steps in enzymatic ca-
talysis
gated reactions; permeation 
of ions or water through 
channels; ‘caging’ eects
protein folding
activity of molecular ma-
chines (e.g., ribosomal 
translation of mRNA)
loop motions (≈ 5-20 Å scale)
rigid-body motions
side-chain rotation (exposed) side-chain rotation (buried)
peptide 
cis/trans 
isomerization
δtMD
1975 1995 2005 2010
An Introduction to Biomolecular Simulations and Docking
Figure 1: Molecular interactions over many length-scales
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Figure 3: Phase space and its sampling via MD and MC
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Figure 6: Protein−ligand docking in action: A computed grid
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